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ABSTRACT
BIOMONITORING POLYBROMINATED DIPHENYL ETHERS IN
LACTATING WOMEN
by
Rebecca L. Dunn
University of New Hampshire, September 2008
Breast milk is a valuable biological specimen for biomonitoring lipidsoluble polybrominated diphenyl ethers (PBDEs). The goal of this project was to
determine the levels of PBDEs in breast milk of lactating women from the
Seacoast region of New Hampshire and to examine potential relationships
between PBDE levels in breast milk and stage of lactation, maternal
characteristics, living environment and dietary intake. Forty women, ages 22 to
40, provided up to three breast milk samples at the end of their first, second and
third month of breastfeeding for evaluation of day-to-day and month-to-month
variation in PBDE levels. Participants were asked to complete four
questionnaires, which provided maternal, living environment, and diet
information. The sum of PBDE (IPBDE) congeners found in breast milk was
defined as: BDE-28/33, 47, 85, 99, 100, 153, 154, and 183. The IPBDE
concentrations in breast milk over the three-month collection period ranged from
6.5 to 166.7 ng/g lipid. The median for the three-month period was 29.7 ng/g.
BDE-47 was the predominant congener; however, BDE-153 predominated in
20% of the participants’ samples from each month. Day-to-day variation in
IPBDEs was negligible; there was no significant difference in mean PBDE levels
from month-to-month. Regression analyses revealed relationships between logXI
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transformed PBDE levels in breast milk and questionnaire data. Positive
associations were seen between BDE-153 and age (r= 0.36 p = 0.02), saturated
fat consumption (r= 0.31 p = 0.05), and the home model (r= 0.51 p = 0.004).
There was a negative association between PBDE levels ( I and BDE-47) and
fruit consumption (r= 0.36 p = 0.02, IPBDE). Our results indicate that PBDE
levels in breast milk from New Hampshire are within the range that has been
reported in the U.S., and that levels are stable during the first three-months of
lactation. Our findings revealed a higher predominance pattern with BDE-153
compared to other studies, and indicate that PBDE levels are influenced by age,
diet, and the home environment.

XII
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CHAPTER I

INTRODUCTION

Polybrominated diphenyl ethers (PBDEs) are synthetic flame retardants
that are added to consumer products, such as fabrics, foams, and electronics.
Over time, PBDEs can diffuse out of their products, become airborne or enter
dust, and disperse into the environment and into humans. Due to their
persistent, lipid-soluble characteristics and widespread use in consumer
products, PBDEs are bioaccumulating and have been detected in air, dust,
mammals, and humans - including human breast milk.
Breast milk is a valuable biological specimen for biomonitoring lipidsoluble PBDEs. The purpose of biomonitoring is to document, update, and
expand human exposure information on environmental chemicals (U.S.
Department of Health and Human Services, Centers for Disease Control and
Prevention [U.S. DHHS, CDC], 2005); breast milk biomonitoring studies can
estimate PBDE exposure in both the nursing mother and breastfeeding infant,
but can also provide information about sources of PBDE exposure.
In the U.S., a limited number of studies have reported PBDE levels in
breast milk, with no documentation to date from the state of New Hampshire.
One study in the U.S. has reported rates of PBDE elimination overtime in a small
sample of nursing mothers from California (Hooper et al., 2007), and one has
demonstrated relationships between PBDE levels in breast milk and house dust,
1
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dairy intake, and meat intake (Wu et al., 2007). Given the limited number of
studies in the U.S., there is a need to further document PBDE levels in humans,
examine PBDE levels in breast milk over time, and further evaluate potential
sources of PBDE exposure, all of which contribute to the purpose of
biomonitoring.
The goals of Biomonitoring PBDEs in Lactating Women were to contribute to
the current body of knowledge about PBDE levels in breast milk of lactating
women and to examine potential relationships between PBDE levels in breast
milk and maternal characteristics, living/occupational environment and dietary
intake. This research will provide new knowledge about PBDE levels in the state
of New Hampshire. Specific objectives of the research were:
1.) To develop an informative, yet reassuring tool to educate potential subjects
about the research being done, body burden, PBDEs, and the importance of
breastfeeding.
2.) To determine the levels of PBDEs in breast milk of lactating women from the
Seacoast region of New Hampshire.
3.) To evaluate the relationship between PBDE levels in breast milk and stage
of lactation.
4.) To evaluate the relationship between PBDE levels in breast milk and
maternal characteristics.
5 .)

To evaluate the relationship between P B D E levels in breast milk and dietary

intake.
6.) To evaluate the relationship between PBDE levels in breast milk and
maternal environment.
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CHAPTER II

REVIEW OF THE LITERATURE

biomonitorinq

Biological monitoring, or biomonitoring is the measurement of
environmental chemicals, their metabolites, or their reaction products in the
human body, specifically through blood, urine, saliva, breast milk, adipose or
other tissue (Needham et al., 2007; U.S. DHHS, CDC, 2005). The CDC (2005)
defines an environmental chemical as “a chemical compound or chemical
element that is present in air, water, food, soil, dust or other environmental media
/

(e.g., consumer products)” (p.1). The steady increase in the production and use
of chemicals in the U.S. since World War II, particularly industrial and agricultural
chemicals, has encouraged biomonitoring initiatives worldwide.
The purpose of biomonitoring is to document, update and expand human
exposure information on environmental chemicals. Specific uses of
biomonitoring data have been identified by the CDC, which are to: a.) determine
which chemicals are in the U.S. population and at what levels; b.) determine the
prevalence of people with levels of chemicals that are above known toxicity
levels; c.) establish reference ranges of chemicals that allows for identification of
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a person or group with high exposure; d.) determine if human exposure levels
are higher among some groups as compared to others; e.) follow time trends in
levels of human exposure; and f.) set research priorities on human health effects
(U.S. DHHS, CDC, 2005). Assessing human exposure to environmental
chemicals is an important aspect of the exposure-effect continuum (Figure 1)
(Needham et al., 2007; Sexton et al., 2004).

Exposure source
water, air, food, soil, dust, sediment, personal
care products, in utero

Exposure surfaces:
inhalation, ingestion, dermal contact

Human exposure/internal dose
(biomonitoring)

MetaSolism
Elimination

t i

Distribution

'Elimination

Target tissue dose
(occasional biomonitoiing)

Biologically effective dose

Health effect
Note. Adapted from “Strategic Biomonitoring Initiatives: Moving the Science Forward," by J. Angerer, M.G. Bird, T. Burke, N.G. Doerrer,
L.L. Needham, S.H. Robison, L Sheldon, and H. Zenick, 2006, Toxicobgical Sdences, 93, p. 5. Copyright 2006 by Oxford Univa^ity Press.

Figure 1. Exposure to health effect continuum.
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With more than 80,000 chemicals in use, numerous governmentsponsored programs have been initiated in the U.S. to meet public and private
)■

demands for biomonitoring including: the National Health and Nutrition
Examination Survey, the National Environmental Tracking Program, the National
Children’s Study, the Agricultural Health Study, the Farm Family Exposure Study,
the National Human Exposure Assessment Survey, and the Center for Children’s
Environmental Health and Disease Prevention Research (Albertini et al., 2006).
Biomonitoring has many uses in the area of environmental public health; it seeks
to expand the current state of knowledge on assessing human exposure to
chemicals (internal dose), exposure sources and pathways, and potential health
effects (Figure 1) (Needham et al., 2007).
Assessing Human Exposure
The CDC’s National Biomonitoring Program is continuously assessing the
U.S. population’s exposure to environmental chemicals through the collection of
biological samples (blood and urine). The CDC began biomonitoring in 1976
through the second National Health and Nutrition Examination Survey (NHANES
ft

II) by measuring blood lead levels in a representative sample of the U.S.
population (Sexton et al., 2004). Biomonitoring continued with NHANES III, but
data collection was sporadic until 1999 when NHANES became a continuous
survey gathering data on a new national sample every two years.
In March 2001, the CDC’s Environmental Health Laboratory released the
first National Report on Human Exposure to Environmental Chemicals, which
provided biomonitoring data on 27 chemicals (U.S. DHHS, CDC, 2001). The
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report provided exposure levels on 27 environmental chemicals for the U.S.
population. Since this time, two additional reports have followed with the most
recent released in July 2005, which provided exposure data in a sampling of
2,400 people for 148 environmental chemicals (U.S. DHHS, CDC, 2005).
The groups of environmental chemicals in the third report included the
following: metals; tobacco smoke; polycyclic aromatic hydrocarbons;
polychlorinated dibenzo-p-dioxins, polychlorinated dibenzofurans, and coplanar
and mono-ortho-substituted polychlorinated biphenyls; non-dioxin-like
polychlorinated biphenyls; phthalates; phytoestrogens; organochlorine pesticides;
organophosphate pesticides; herbicides; pyrethroid pesticides; other pesticides;
and carbamate insecticides (U.S. DHHS, CDC, 2005). The chemicals for
biomonitoring in the first three reports were selected based on scientific data. In
upcoming reports, however, chemicals will have been nominated by the public,
and prioritized and selected by a panel of experts from the CDC.
Recommendations have been set forth by the National Research Council (2006)
to include other agencies for chemical selection, such as the Environmental
Protection Agency, the National Toxicology Program, the Food and Drug
Administration, the U.S. Department of Agriculture and the National Institute of
Environmental Health Sciences. With an interagency approach to selecting
priority chemicals, this will enhance the overall purpose of biomonitoring.
Assessing Exposure Sources and Surfaces
Needham and colleagues (2005) described exposure as the contact
between a source and a target where contact occurs at an exposure surface
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during an exposure period. As depicted in Figure 1, an exposure source is
water, air, food, soil, dust, sediment, personal care products, and in utero
exposure. Humans (targets) encounter exposure sources depending on various
events in their lifetime (exposure period) which allows for uptake through
exposure surfaces (e.g. nasal passages, mouth and skin).
Biomonitoring data can assist in examining overall exposure sources and
surfaces; it works in the reverse direction on the exposu re-effect continuum by
going from human exposure to exposure source (Albertini et al., 2006; Needham
et al., 2007). Biomonitoring data that is coupled with other assessment methods,
such as questionnaires and personal monitoring can provide information that
potentially links internal dose to exposure source.
The collection of serial analytical measurements of exposure sources are
necessary for identifying concentrations, variability, and trends of environmental
chemicals, which can assist in developing health indices (Bahadori et al., 2007;
Needham et al., 2007). For example, the U.S. Environmental Protection
Agency’s (U.S. ERA) reference dose can provide an estimate of a daily exposure
level that is npt expected to cause adverse health effects over one’s lifetime
(Needham et al., 2007). The relationship between one’s exposure, the expected
internal dose concentration, and the potential health implications are of particular
interest to environmental public health scientists.
Assessing Potential Health Effects through Biomonitorinq
In the Third National Report on Human Exposure to Environmental
Chemicals, the CDC (2005) states, “the measurement of an environmental
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Chemical in a person’s blood or urine does not by itself mean that the chemical
causes disease ” (p. 4). One of the greatest challenges with biomonitoring is
evaluating the potential health implications of the data.
The ability to interpret the results of biomonitoring data in the context of a
health risk assessment lags behind current analytical methodology (Hays et al.,
2007). Human health risk assessment of environmental chemicals can use an
interpretative method that compares estimated daily doses to health-based
criteria for acceptable, safe, or tolerable intakes. These comparisons can assess
whether estimated doses exceed health screening levels. However,
biomonitoring data measures environmental chemical concentrations in biological
specimens (e.g. blood, urine) rather than estimated intake doses.
Quantitative criteria are needed for interpretation of environmental
chemical concentrations in biological specimens and their relevance to human
health. In order for these criteria to be developed, advances are necessary in the
following areas: toxicologic, epidemiologic and toxicokinetic data, health-based
values such as reference doses, health-risk data, and exposure assessment data
(National Research Council, 2006). The National Research Council (2006)
describes two primary options for interpreting biomonitoring data, which are the
descriptive approach and the risk-based approach.
The descriptive approach offers a statistical presentation of the data
(National Research Council, 2006). For example, in the Third National Report on
Human Exposure to Environmental Chemicals (2005), descriptive statistics, such
as geometric mean and percentiles, are used to present the data. The use of
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percentiles allows for the data to be distributed in reference ranges. Reference
ranges offer a point of comparison for individuals and subgroups, and also allows
health care professionals to determine high levels of exposure (National
Research Council, 2006; U.S. DHHS, CDC, 2005). The descriptive approach is
an important step in the interpretation of biomonitoring data; it begins to lay the
groundwork for risk-based approaches (National Research Council, 2006).
The risk-based approach is complex, as it uses toxicologic, epidemiologic,
or pharmacokinetic modeling information (National Research Council, 2006).
These methods evaluate the risk that is associated with the amount of
environmental chemical present in the body.
There are several interpretative risk-based options: biomonitoring-based
risk assessment, traditional risk assessment, and biomonitoring-led n'sk
assessment (National Research Council, 2006). Biomonitoring-based risk
assessment uses biomarker-response relationships that have been established
in epidemiologic studies; however, there are only a few environmental chemicals
that have enough data to use this approach to interpret risk. Traditional risk
assessment evaluates exposure pathways to estimate the human dose; the dose
is then used to calculate health risk as compared to health-based criteria for
acceptable, safe, and tolerable intakes. The third option, biomonitoring-led risk
assessment, uses quantitative data on the absorption, distribution, metabolism,
and excretion (pharmacokinetics) of an environmental chemical. With this option,
pharmacokinetic modeling techniques are used to convert biomonitoring data into
a format, such as a human-exposure dose format, that provides exposure
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information in risk assessments. Biomonitoring-led risk assessment relies upon
an expansive biomonitoring and toxicology database for the environmental
chemical of interest; therefore, its uses could be limited depending upon the
availability of data for an environmental chemical.
Typically, interpretation of biomonitoring data ends with the observation
that the chemical is present in humans (descriptive approach), which becomes
the message that is communicated to the public, and can often induce anxiety.
The challenge for environmental health scientists is to interpret the health
implications of biomonitoring data and appropriately communicate the results to
the public (National Research Council, 2006).
Communicating Results of Biomonitorinq Studies
Biomonitoring data presents the results of environmental chemical levels
in humans; this makes human exposure data personal (National Research
Council, 2006). Brody and colleagues (2007) address the ethical challenges that
are associated with reporting personal exposure information for environmental
chemicals. Deciding whether or not to report individual levels of environmental
chemicals requires researchers to consider several principles for protecting
human participants: autonomy; beneficence; nonmalfeasance; and justice.
The principles of autonomy and justice support the practice of providing
participants with their individual results (Brody et al., 2007). Autonomy is an
individual’s right to know in order to make decisions based upon the research
results while justice emphasizes the provision of information that highlights the
benefits and harms as it applies to different groups of people. The principles of

10
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autonomy and justice are typically seen in community-based participatory
research and activist exposure studies where participants receive their individual
results.
The clinical medicine model emphasizes the principles of beneficence and
nonmalfeasance in which participants may not be provided with their individual
results (Brody et al., 2007). These principles support the practice of maximizing
benefits and minimizing potential harm, particularly when the meaning of results
is unclear; and can lead to situations that cause fear, anxiety, and unnecessary
interventions.
The challenge with each of these principles is balancing the benefits and
harms that are associated with reporting individual exposure levels; this balance
should be based on the available research for the environmental chemical.
However, regardless of whether individual or group levels are reported, it is
important to ensure that communication of results includes proper interpretation
and use of biomonitoring data.
The National Research Council (2006) emphasizes early planning as an
important component in communicating biomonitoring information. Early
planning enables researchers to assess the needs of the study population and to
establish partnerships with other constituencies in formulating public health
messages. Early planning also encourages researchers to consider both
practical and research-based communication recommendations.
Practical recommendations focus on educational aspects, whereas,
research-based recommendations promote the advancement of biomonitoring

11
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communication (National Research Council, 2006). Practical biomonitoring
communication recommendations highlight the following areas; communication
sponsorship, use of consistent terminology and concepts, expansion of
biomonitoring education to the public, communication training for organizations
and professionals, and public documentation of ways to reduce exposures.
Research-based recommendations emphasize the following areas: identification
of scientist and non-scientist beliefs about exposures and health effects,
assessment of current biomonitoring communication methods and its impact on
the public, identification of the public’s perception regarding uncertainties in
biomonitoring, and identification of the public’s beliefs about risk reduction. In
addition to these recommendations, Bates and colleagues (2005) further suggest
that researchers communicate accessible results of biomonitoring research. For
example, researchers should distinguish between statistically significant effects
and clinically significant effects. These recommendations are a crucial
component in creating and building an infrastructure for communicating results of
biomonitoring studies.
If communication is lacking between biomonitoring researchers and the
general public, then the results of biomonitoring studies are subject to
misinterpretation and misuse, which can lead to public health messages that
induce confusion, conflict and anxiety. For example, occasionally, the media will
become aware of biomonitoring research, and will provide a condensed,
simplified version of the results (Bates et al., 2005). Often, these types of
messages present a communication risk, particularly if the biological specimen is

12
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sensationalized with a degree of harm, which can happen when environmental
chemicals are detected in breast milk.
breast milk biomonitorinq
The use of breast milk as a biological matrix for biomonitoring studies can
estimate environmental chemical exposure in both the nursing mother and
breastfeeding infant. Determining infant exposure can be done by measuring the
concentration of the environmental chemical in breast milk and estimating infant
intake of milk (Lovelady et al., 2002).
Breast milk can be a convenient and noninvasive means for estimating
environmental chemical exposures as compared to other biological matrices,
which may require surgical intervention. (Hooper & She, 2003). However, it is
important that sampling does not burden the mother or compromise the infant’s
nutrition. There are guidelines that should be considered when determining the
study design of breast milk biomonitoring programs.
Studv Design Considerations
Participant Characteristics. There are a number of influential participant
characteristics that can affect environmental chemical concentrations in breast
milk samples. Fenton et al. (2005), Lovelady et al. (2002), and the World Health
Organization (WHO) (2004; 2007) have described characteristics that should be
taken into account when measuring environmental chemicals in breast milk.
Fenton and colleagues (2005) list the following characteristics that should be
considered: maternal information such as age and body mass index, lifestyle
history such as dietary intake, smoking, and medication use, obstetric history.
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occupational history, and prior breastfeeding history. The WHO (2004; 2007)
provides specific recommendations for participant characteristics in breast milk
biomonitoring studies including: first-time mothers, healthy mother and infant,
mothers under the age of 30, and primarily or exclusively breastfeeding. The
most recent WHO (2007) guidelines recommend that mothers should have
resided in the same geographical location for at least the past 10 years, although
the residency time frame could pose a challenge for recruiting young mothers
who are under the age of 30 into breast milk biomonitoring studies. In addition to
considering maternal characteristics for breast milk biomonitoring studies, it is
recommended that researchers implement a milk collection protocol.
Breast Milk Expression and Collection. Lovelady and colleagues (2002)
recommend collecting and analyzing individual breast milk samples from women
rather than pooling samples. Pooling samples is less expensive than analysis of
individual samples, but analyzing individual milk samples enables researchers to
examine potential associations between participant characteristics and
environmental chemical levels. It is also important for researchers to consider
individual expression and collection variables that can affect milk composition.
Study design recommendations have suggested hand-expressing
samples for breast milk biomonitoring research in order to limit sample
contamination from breast pumps. However, recent research by Hooper and
colleagues (2007) found that breast pumps can be used for expression of
samples as they maintain accuracy of environmental chemical levels when
compared to hand-expressed samples. Use of a breast pump is recommended if
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researchers wish to receive samples that contain hind milk, which have a higher
fat content than foremilk (Lovelady et al., 2002). Obtaining a sample that
contains hind milk is useful when analyzing lipid-soluble environmental chemicals
and usually requires a complete milk expression from one breast. This method
of milk collection enables researchers to estimate exposure of lipid-soluble
environmental chemicals in individual infants: however, it is not a typical practice
when examining concentrations in the mother because levels are presented on a
lipid-adjusted basis. Participant compliance and retention are greater when
breast pumps are provided for milk collection, and are especially helpful for
women who find manual pumping difficult.
Participant retention can be dependent on timing of sample collection.
Lovelady et al. (2002) and the WHO (2007) suggest waiting until week two or
three to begin sampling to ensure that lactation has been well established. It is
also recommended to collect samples within the first three- months postpartum
as early weaning and lower exclusive breastfeeding rates can often be a
recruitment and retention factor in breast milk biomonitoring studies, particularly
in the U.S. For example, data collected in the U.S. from the National
Immunization Survey in 2004, reported that 30.5% of infants were exclusively
breastfed at three months, which then decreased to 11.3% at six months of age
(U.S. DHHS, CDC, 2007). Therefore, collecting breast milk samples in the first
few months postpartum could lead to higher participant retention rates.
Lovelady et al. (2002) suggests collecting samples at different time
intervals, such as at month one, two and three, to evaluate for changes in
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environmental chemical levels over time. Additionally, the time of day and time
elapsed between feedings should be consistent among participants as these
variables have been found to contribute to daily variations in the fat content of
milk samples, which is an important consideration when assessing exposure of
lipid-soluble environmental chemicals in individual infants. Ruel and colleagues
(1997) found that the average concentration of fat in a 24-hour pooled sample
was 4.2%: the time of day that was in agreement with this percentage was
between the hours of 6 a.m. and 8 a.m. Since breast milk composition varies
from feed to feed, day to day, and month to month, it is recommended to
standardize the sample collection period.
Prior to collecting milk samples, participants should be provided with
guidelines for washing the breast and equipped with proper storage containers
for their milk samples. Lovelady and colleagues (2002) recommend that mothers
wash the breast with a mild, detergent-free soap, and rinse the breast with
distilled water to limit potential contamination from creams and ointments.
Additionally, it is recommended that participants be provided with suitable
storage containers. The U.S. EPA (2003) and the WHO (2007) suggest amber
glass bottles that have Teflon fitted lids and have been detergent-water washed,
then solvent-rinsed prior to use. The recommendations for containers are
necessary as some environmental chemicals are sensitive to ultraviolet light, and
if lipid-soluble, may adhere to plastic containers during their handling and
storage.
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Breast Milk Sample Handling. Storage and Analysis. Once breast milk
samples are placed into the appropriate storage container with a participant
identification number, they can then be stored in a refrigerator for up to 72 hours
(4°C) or placed in the freezer (-20°C) (WHO, 2007). Frozen breast milk samples
can be stored at -70° for an indefinite period (Lovelady et al., 2002).
Transportation of frozen samples should be on dry ice.
There are several analytical methods for measuring environmental
chemicals in breast milk; however, regardless of the selected approach, the
process typically consists of the following general steps: 1.) sample preparation,
which includes lipid determination and “cleanup”; 2.) sample analysis, which
involves chromatographic and detection steps; and 3.) data analysis and
evaluation (Needham & Wang, 2002). Selecting an analytical method depends
upon the classification of the analytes of interest. Environmental chemicals can
be classified as inorganic or organic compounds, and further categorized as
volatile or semi-volatile organic environmental chemicals. Regardless of the
analytes of interest and the selected analytical approach, there should be
methodological goals built into the measurement process that address quality
assurance and control to determine specificity, sensitivity, precision, and
accuracy of the technique.
Advantages and Disadvantages of Breast Milk Biomonitorinq Programs
Breast milk Is a valuable matrix for monitoring body burdens of
environmental chemicals; however, there are positive and negative aspects when
using breast milk to assess human exposure to environmental chemicals (Fenton
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et al., 2005; Hooper & She, 2003). Fenton and colleagues (2005) identify the
following limitations: 1.) interpretation and communication of study results, which
have the potential for affecting breastfeeding rates if inaccurate messages are
provided to the public; 2.) recruitment challenges if studies are limited to women
who are exclusively breastfeeding; 3.) sampling challenges if analytes of interest
have short half-lives; 4.) insufficient data on depuration (elimination kinetics),
which limits estimates on infant intake; and 5.) the inability to generalize the
results given the selected marker of exposure. Even though there are limitations
associated with breast milk biomonitoring studies, several positive aspects have
been identified: 1.) the collection of serial samples, which provides information on
environmental chemical levels overtime; 2.) the use of one biological specimen
to assess exposure of the mother and infant; 3.) a better understanding of body
burden of breastfed infants; and 4.) the collection of a biological specimen with a
high fat content, which is an important consideration for lipid-soluble
environmental chemicals - particularly those that have been steadily rising in
their production, use, and presence in the environment and in humans, such as
synthetic flame retardants.
flame retardants
Every twenty seconds, a fire department responds to a fire somewhere in
the U.S. (Karter, 2006). In 2005, fires were responsible for 3,675 civilian-related
deaths, 17,925 civilian injuries, and greater than 10 billion dollars in property
damage. Since 1977, fire incidence has decreased from 3,264,000 to 1,602,000
due to fire prevention polices that require the presence of flame retardant
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Chemicals in a variety of different products (Birnbaum & Staskal, 2004; Karter,
2006).
Flame retardants are synthetic chemicals that are added to materials
either during or after manufacturing in order to interfere with the combustion
process (Bromine Science and Environmental Forum [BSEF], 2000). This
interference can occur during heating, decomposition, ignition or flame spread.
There are over 175 different types of flame retardants that are divided into four
major classes: halogenated organic (usually brominated or chlorinated),
phosphorus-containing, nitrogen-containing, and inorganic flame retardants
(Birnbaum & Staskal, 2004; BSEF, 2000). The brominated flame retardants
(BFRs) are the most widely used due to their low cost and high performance
efficiency. Compared to other flame retardants, consumer products use a smaller
quantity of BFRs for a higher fire resistance (BSEF, 2000).
Brominated Flame Retardants
There are five major classes of BFRs, including brominated bisphenols,
cyclododecanes, phenols, phthalic acid derivatives, and diphenyl ethers
(Birnbaum & Staskal, 2004). The most widely used BFRs are
tetrabromobisphenol A, hexabromocyclododecane, and three commercial
products of polybrominated diphenyl ethers known as decabromodiphenyl ether,
octabromodiphenyl ether and pentabromodiphenyl ether (Birnbaum & Staskal,
2004; BSEF, 2000). In 2001, polybrominated diphenyl ethers (PBDEs)
represented one of the highest production volumes of BFRs in the U.S. with a
total market consumption of 33,100 metric tons (BSEF, 2003).
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Polybrominated Diphenyl Ethers
There is the potential for 209 PBDE yariants. Each yariant can be
identified by the number and position of bromine atoms, also known as a PBDE
congener (Figure 2) (U.S. EPA, 2006).

o

6
Br.

Key: PBDE variants; x + y = 1 t o 1 0 bromines

Figure 2. General structure of PBDEs

Howeyer, there are fewer PBDE congeners in commercial mixtures than
theoretically possible due to their instability and debromination (Birnbaum &
Staskal, 2004). Three commercial PBDE products - pentaBDE, octabBDE and
decaBDE - contain mixtures of yarious PBDE congeners, are used in different
products, and yary in their market demand (Table 1).
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The total U.S. market demand values for pentaBDE and octaBDE are expected
to drop to zero because Great Lakes Chemical Corporation, the soie U.S.
manufacturer of pentaBDE and octaBDE, discontinued production of these two
commercial products at the end of 2004 (U.S. EPA, 2006).
Even though PBDEs have been in use since the 1970s, they have
captured the attention of policymakers, firefighters and the general public,
worldwide, over the past 15 years. The European Union adopted legislation in
2002 that prohibited the use of pentaBDE and octaBDE, which took effect in
August 2004 (U.S. EPA, 2006). Several states in the U.S. have also adopted
bans on the distribution of products that contain pentaBDE and octaBDE,
including California, Maine and New York. Although decaBDE has the highest
annual global demand at 56,100 metric tons (83% of PBDE demand) (BSEF,
2003), restrictions on its use has been limited. The European Union granted an
exemption on prohibiting the use of decaBDE in October 2005 (U.S. EPA, 2006),
but Washington state recently became the first in the U.S. to have approved
legislation that would ban the use of decaBDE in household goods, which is
scheduled to take effect in 2008 (American Chemical Society, 2007). The
legislation was supported by Washington state fire chiefs and firefighters. Even
though the presence of PBDEs in consumer products such as television sets,
carpet padding, mattresses, chair and couch foams, computers, stereos, and hair
dryers saves lives each year in the U.S., there are concerns with its widespread
use because of increasing environmental and human concentrations.
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Bioaccumulation. Due to their persistent, iipid-soiuble characteristics and
incorporation into a variety of products, PBDEs are bioaccumùlating. PBDE
bioaccumulation is primarily due to PBDE release from consumer products into
the air through normal use, degradation, disposai, and recyciing; additional
release can also occur during PBDE manufacturing and incorporation into
products (Hale et al., 2003). PBDEs are non-chemically bound additives, and
may contribute up to 30% by weight of foams, fabrics and plastics (Hale et al.,
2003; Hooper & She, 2003). Over time, PBDEs can diffuse out of their products,
become airborne or enter dust, and disperse into the environment and into
humans.
PBDEs have been detected in air, house dust, sewage sludge, water,
sediment, and soil (Allen et al., 2007; de Boer et al., 2003; Hale et al., 2002;
Jones-Otazo et al., 2005; Rudel et al., 2003; Wù et al., 2007). It Is suggested
that ingestion of indoor dust is a major exposure pathway for PBDEs in humans
(Allen et al., 2007; Jones-Otazo et al., 2005) and that hand-to-mouth exposure
contributes to people’s Intake of PBDEs (Stapleton et al., 2008).
Studies document PBDE appearance in marine mammals, fish, pet cats,
human tissue, human placenta, and human blood samples (Bradman et al.,
2007; Dye et al., 2007; Gômara et al., 2007; Guvenius et al., 2003; JohnsonRestrepo et al., 2005; Mazdai et al., 2003; Petreas et al., 2003; Rice et al., 2002;
Sandanger et al., 2007; Schecter et al., 2007; Schecter et al., 2005; She et al.,
2002; Sjôdin et al., 1999; Sjôdin et al., 2004; Strand man et al., 2000). Timetrend data from the U.S. indicate increasing PBDE biood concentrations between
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1973 and 2003, and between 1985 and 2002 (Schecter et al., 2005; Sjôdin et al.,
1999).
PBDEs have been detected in various samples of food sources from
Japan, Spain & U.S. (Bocio et al., 2003; Huwe & Larsen, 2005; Huwe et al.,
2002; Ohta et al., 2002; Schecter et al., 2006; Schecter et al., 2004). Bocio and
colleagues (2003) found that foods of animal origin, fish, and fats and oiis have
higher ievels of PBDEs as compared to grains, fruits and vegetables. Higher
PBDE levels were ejected by Ohta and colleagues (2002) In fish sampies as
compared to beef and chicken; however, spinach, potato and carrot had higher
PBDE concentrations as compared to beef and chicken. Recent work by
Schecter et al. (2006) confirmed that the highest PBDE levels in a U.S. market
basket survey were detected in fish samples followed by dairy products and
meat. PBDEs have also been detected in another biologicai matrix - studies from
Canada, China, Czech Repubiic, Denmark, Faroe Isiands, Finland, Italy, Japan,
Poland, Spain, Sweden, Taiwan, Turkey, United Kingdom and U.S. report that
PBDEs appear in human breast milk (Akutsu et al., 2003; Bi et al., 2006; Chao et
al., 2007; ErdogruI et al., 2004; Eslami et al., 2006; Fângstrôm et al., 2005;
Gômara et al., 2007; Hooper et al., 2007; Ingelido et al., 2007; Jaraczewska et
al., 2006; Johnson-Restrepo et al., 2007; Kalantzi et al., 2004; Kazda et al.,
2004; Lind et al., 2003; Lunder & Sharp, 2003; Main et al., 2007; Meironyté et al.,
1999; Norén & Meironyté, 2000; Ohta et al., 2002; Ryan & Patry, 2000; Ryan et
al., 2006; Schecter et al., 2005; Schecter et al., 2003; Schuhmacher et al., 2007;
She et al., 2007; Strand man et al., 2000; Wu et al., 2007).

24

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

Levels of PBDEs in humans vary geographically, however, the highest
PBDE concentrations in humans have been reported in the U.S. (Hites, 2004).
With the appearance of PBDEs in the environment and concentrations in
humans, this raises concern about the potential human health implications.
Heaith Implications. With a simiiar chemicai structure to polychiorinated
biphenyls (PCBs) and pesticides such as dichlorodiphenyltrichloroethane (DDT),
both of which have been banned due to their adverse heaith outcomes (Hooper
& McDonaid, 2000), as weil as structural similarities to thyroid hormone, research
is necessary to understand the human heaith impiications of PBDEs - which are
currently unknown.
There are a limited number of epidemiological studies, to date, that have
examined PBDE concentrations and human health. In central Taiwan, increased
PBDE levels in human breast milk were related to lower birth weight and length,
head and chest circumference, and body mass index in newborns (Chao et al.,
2007). A recent study by Main and coileagues (2007) revealed that the
concentration of PBDEs in breast miik was significantly higher in infant boys with
congenital cryptorchidism as compared to controls. A case-control study by,
Harden and colleagues (2001) found higher BDE-47 ievels in adipose
tissue/biood sampies from adult Swedish patients with non-Hodgkin’s iymphoma
when compared to age-matched controls. Furthermore, it was shown that the
median titer to Epstein-Barr early antigen was higher among cases than controls,
and the highest risk for non-Hodgkin’s lymphoma was found with high BDE-47
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concentrations and an elevated titer of antibodies to the Epstein-Barr virus
antigen.
Research on the biologicai effects of PBDEs has been conducted mostly
in experimental animal models. PBDEs have been shown to cause adverse
effects in severai biological end-points. The greatest concern for the potential
health implications of PBDEs comes from research that has examined
developmental neurotoxicity in mice (Birnbaum & Staskal, 2004). Exposure to
PBDEs adversely affects spontaneous behavior, and causes learning and
memory deficits in mice (Branchi et al., 2002; Eriksson et al., 2001, Viberg et al.,
2003; Viberg et al., 2006). The mechanisms for these behavioral and cognitive
deficits are not known, but research suggests alterations in cholinergic receptors,
arachidonic acid reiease, and thyroid hormone homeostasis (Birnbaum &
Staskal, 2004).
Thyroid hormones influence a variety of physiological processes In the
body such as regulating cellular metabolism and its crucial role in the
development of the central nervous system. Research has demonstrated that
hypothyroidism during pregnancy can adversely affect a child’s subsequent
performance on neuropsychological tests (Haddow et al., 1999). PBDEs have
been shown to disrupt thyroid hormone homeostasis in rats and mice. Studies
have shown alterations in thyroid hormone levels, particularly decreased
thyroxine levels, after exposure to PBDEs (Fowles et al., 1994; Hallgren et al.,
2001 ; S karman et al., 2005; Zhou et al., 2001 ; Zhou et al., 2002). There are
several different mechanisms as to how PBDEs interact with thyroid hormone
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homeostasis, including alterations in piasma transport of thyroxine, induced
hepatic enzyme activities resulting in increased metabolism of thyroxine, and
possibiy direct effects on the thyroid gland (Darnerud et al., 2007; Lllienthal et al.,
2006; Meerts et al., 2000).
In addition, PBDE-induced imbalances in steroid hormone homeostasis
i
.
and other steroid-related effects have been documented in vivo and in vitro. A
.

.

.

recent study by Lllienthal and colleagues (2006) documented the effect of BDE99 on sex steroids, sexual development, and sexually dimorphic behavior in the
offspring of treated pregnant rats. Exposure to PBDEs resulted in decreased
circulating concentrations of estradiol and testosterone in male offspring, delayed
puberty onset in female offspring, a reduction in the number of primordial/primary
and secondary ovarian follicles, and an increased sweet preference in male
offspring. The increased sweet preference in male offspring was characterized
as sexually dimorphic behavior indicating behavioral feminization. Meerts and
colleagues (2001) examined the estrogenicity activity of 17 PBDE congeners and
3 hydroxylated PBDEs in vitro using an estrogen-responsive luciferase cell line.
It was found that cellular exposure to PBDE congeners and hydroxylated PBDEs
induced the estrogen receptor signal transduction pathway in vitro. The most
potent effects were seen with BDE-100, BDE-75, BDE-51, BDE-119 and the T 3 like and Ta-like hydroxylated PBDE compounds. The potential endocrinedisrupting effects of PBDEs could impact growth and development of the central
nervous system and reproductive tissues as well as metabolism.
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In 2002, a hypothesis was generated on the role of synthetic chemicals in
the giobai obesity epidemic (Baiilie-Hamilton, 2002). Hoppe and Carey (2007)
pursued this hypothesis with the notion that PBDEs disrupt hormonally-mediated
adipose tissue metabolism. After male rats were exposed to pentaBDE daily for
4 weeks, an increase in lipolysis and a decrease in insulin sensitivity was seen,
which is consistent with the metabolic effects observed in obese animals.
Further research is currently being pursued in this area, so the long-term effects
of PBDEs on adipose tissue metabolism and its relationship to the promotion of
obesity are not yet clear.
There is limited information as to how PBDE toxicity in animals translates
to human health effects. McDonald (2005) recently examined PBDE exposure
and risk assessment by comparing PBDE concentrations in humans with
concentrations that were associated with developmental neurotoxicity and
reproductive effects in rodents. Estimates of human daily PBDE intake was
calculated from biomonitoring literature on PBDE concentrations in serum,
adipose tissue, and breast milk from women in the U.S. Daily intake data for all
human matrices were combined and the 95*^ percentile was determined, which
represented high-end exposures in the U.S. population. The 95‘*^ percentile
depicted the iipid-normalized PBDE concentrations in humans, which was
compared to an estimate of lipid-normalized tissue concentrations in rodents.
The rodent-to-human ratio of PBDE tissue concentration was then used as a
margin of exposure. The margin of exposure was defined as how many folds
higher is the rodent dose that caused no effects from the human dose; the
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smaller the distance between doses the greater the heaith concern. Using this
reverse dosimetry pharmacokinetic modeling approach, McDonald (2005) found
that there was a small margin of exposure for behavioral and reproductive effects
with alterations in maie fertility and ovary cells in females. A risk-assessment
approach such as this enables researchers to evaluate biomonitoring data from a
toxicity standpoint.
Toxicoioqv. The toxicology of the three commercial mixtures (pentaBDE,
octaBDE, and decaBDE) and some of the individual PBDE congeners has been
reviewed extensively by Darnerud et al. (2001), Gill et al. (2004), and Hardy
(2002). The toxicological effects correspond with degree of bromination; the
toxicity of the tetra through deca PBDE congeners decreases with increasing
levels of bromination.
The toxicological effects of PBDEs have primarily been documented in
animal models with almost no available data in humans (Birnbaum & Cohen
Hubai, 2006). Overall, the acute toxicity of the commercial products is low when
administered through the oral, dermal or pulmonary routes; however, differences
exist between the three commercial products and their toxicological effects in
repeated dose studies (Darnerud et al., 2001 ; Gill et al., 2004; Hardy, 2002). For
example, oral administration of decaBDE appears to be less acutely toxic as
compared to penta and octaBDE. Oral administration of decaBDE to mice and
rats at 10% and 5% of their diet for 14 and 90 days, respectively, produced no
adverse effects on appearance, behavior, body weight gain, and food
consumption (U.S. DHHS, National Toxicology Program, 1986); however, chronic

29

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

(2 years) dietary exposure to decaBDE has displayed evidence of
carcinogenicity. Orai administration studies have aiso been conducted in rats
with dietary exposure to octaBDE with doses of up to 1000 mg/kg/day (WHO,
1994). These studies have shown no effect on appearance, behavior, or
mortality, however, hepatotoxicity was observed. Zhou and colleagues (2001)
examined the dose-response relationships of 4-day exposure to the three
commercial mixtures on thyroid hormone concentration and hepatic enzyme
activities. The octa and pentaBDE formulations caused dose-dependent
reductions of thyroxine and inductions of hepatic enzymatic activity.
Out of the three commercial mixtures, penta and octaBDE appear to have
the most pronounced dose-dependent toxicity effects in subacute and subchronic
animal studies (Darnerud et al., 2001; Gill et al., 2004; Hardy, 2002). The
differences in toxicity effects are likely due to variations in absorption,
metabolism, and elimination of the individual PBDE congeners from each of the
commercial mixtures.
Absorption. Metabolism and Excretion. PBDE toxicokinetics (absorption,
elimination, and enzyme induction and metabolism) has been studied primarily in
experimental animal models, both in vitro and in vivo. Oral absorption and
metabolism of the individual PBDE congeners varies depending upon the degree
of bromination (Gill et al., 2004). Once PBDE exposure has occurred, it's been
reported that the higher the degree of bromination, the lower the absorption rate
(Birnbaum & Staskal, 2004). Historically, decaBDE has been shown to be poorly
absorbed through the oral route due to its high molecular mass (Darnerud et al..
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2001; U.S. DHHS, National Toxicology Program, 1986); however, recent
research has demonstrated that decaDBE can be absorbed orally at greater than
10% of the dose in rats (Morck et ai., 2003). Lower brominated congeners, such
as BDE-47 (tetra) and BDE-99 (penta), have been shown to have an oral
absorption rate of 93% and greater than 50% in mouse and rat models,
respectively (Hakk et al., 2002; ôrn & Klasson-Wehler, 1998). A higher
absorption rate of lower brominated PBDE congeners leads to a greater
likelihood for tissue bioaccumulation.
Lipophilic tissues tend to be the preferred sites for PBDE disposition;
however, recent work by Inoue and coiieagues (2006) evaluated molecular
descriptors (e.g. hydrophilicity, molecular size, poiar surface area) for PBDEs in
human serum and breast milk samples, and found correlations with the
milk/serum partition coefficients. The structure-activity relationship suggested
that PBDE values in serum and breast milk are related to each other; however,
BDE-209 was the predominant congener in serum and BDE-47 was the .
predominant congener in breast milk.
The congener with the greatest concentration in most biological tissues is
BDE-47, followed by BDE-99 or BDE-153 depending on the species (Hakk et al.,
2002; Hites, 2004). In 2002, Hakk and colleagues found that BDE-99 had the
highest tissue concentrations in adipose, adrenals, gastrointestinal tract, and skin
in male rats; however, the distribution pattern of BDE-99 did not consistently
correlate with tissue lipid content. Other studies have shown similar results with
regard to PBDE disposition and its preference to lipophilic tissues. Orn and
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Klasson-Wehler (1998) found that BDE-47 had the highest concentration in
adipose tissue, but it was also detected in lung, kidney and brain tissues. Both of
these studies also examined routes of elimination, it was found that fecai and
urinary excretion were the routes of PBDE elimination, both the parent
compounds and their metabolites.
The commercial PBDE mixtures and selected individual congeners have
been shown to Induce Phase I cytochrome P450 monooxygenase (GYP)
enzymes and Phase II conjugation enzymes in the liver, which are responsible
for detoxification (Hakk & Letcher, 2003). The penta and octaBDE commercial
mixtures have been shown to induce GYP enzymes (GYP1A1, GYP1A2,
GYP2B1) in rats as indicated by increased activity of liver microsomes, such as
ethoxyresorufin-O-deethyiase and pentoxyresorufin-O-deethylase, as well as
Phase II induction of uridinediphosphate-glucuronosyltransferase (von Meyerinck
et al., 1990; Zhou et al., 2001). When Zhou and colleagues (2001) compared the
three PBDE commercial mixtures, they found that decaBDE had no significant
effects on the measured Phase 1 and Phase 2 enzymes. At the present time,
little is known on PBDE toxicokinetics in humans; however, studies have
examined the estimated half-lives of PBDEs.
Estimated Half-Lives, it is known that PBDEs bioaccumuiate in humans,
but the rate of absorption, the degree of tissue disposition, hepatic enzyme
induction, and metabolism are not known. However, PBDE half-iives have been
estimated in humans. Thuresson and coiieagues (2006) calculated the half-lives
for higher brominated PBDEs (deca, nona, octa, and hepta congeners) using
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serum data from occupationally exposed workers who were sampled before,
during, and after a vacation period. It was found that BDE-209 (deca) had a
short half-life of 11 to 18 days, followed by 18 to 39 days for nona congeners, 37
to 91 days for the octa congeners, and 68 to 120 days for BDE-183 (hepta).
Therefore, the pattern that was observed by Thuresson et al. (2006) indicated the
higher the number of bromine atoms for the PBDE congeners the shorter their
half-lives in serum samples. Data has been presented by Geyer and colleagues
(2004) on the half-lives of the lower brominated PBDE congeners (tetra, penta,
and hexa). Using pharmacokinetic modeling estimates, it was found that the total
body half-lives for tetra to hexa congeners were 1.8 to 6.5 years, respectively.
These results are consistent with McDonald’s (2002) theory that some of the
PBDEs have half-lives that are on the order of years. Since PBDEs can be
absorbed and deposited in human tissue for extended lengths of time,
biomonitoring programs are clearly warranted to assess the extent of exposure.
biomonitorinq PBDEs via breast milk
Breast milk is a valuable biological specimen for biomonitoring PBDEs
given their lipid-solubie characteristics. PBDEs in breast milk were first reported
by Kruger (1988) in German samples, and later by Meironyté et al. (1999) In
Swedish samples. PBDE concentrations in Swedish breast milk samples
increased from 1972 to 1997, and it was determined that levels were doubling
every five years whiie levels of other environmental chemicals (PCBs and DDT)
were decreasing during this same time period (Meironyté et al., 1999; Norén &
Meironyté, 2000). Documenting this exponential increase has resulted in PBDE
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breast milk biomonitoring initiatives around the globe. These initiatives have
focused on: 1.) PBDE levels in breast milk of nursing mothers; 2.) rates of PBDE
eiimination (depuration) from mothers during iactation; 3.) infant intake of PBDEs;
and 4.) potential PBDE sources of exposure.
PBDE Levels in Breast Milk of Nursing Mothers
During the past decade, breast milk biomonitoring has enabled
researchers to document and update human exposure information on PBDE
levels in nursing mothers (Table 2). Currently, the levels of PBDEs in breast miik
samples from the U.S. are 10 to 40 times higher than other regions such as_
Europe and Japan. The reason for the higher leveis of PBDEs in the U.S. is
thought to be due to the market demand for these flame retardants as they are
incorporated into numerous industrial and household products (JohnsonRestrepo et al., 2007). PBDE concentrations in the U.S. indicate differences in
median values depending on the geographical location. For example, median
PBDE values are higher from the Pacific Northwest compared to Massachusetts
(Table 2) (Johnson-Restrepo et al., 2007; She et al., 2007; Wu et al., 2007).
However; one consistent outcome that has been verified in the majority of breast
milk biomonitoring studies, to date, is the predominance of the BDE-47 congener.
Rates of PBDE Elimination from Mothers during Lactation
In addition to documenting PBDE leveis in breast milk. Hooper and
colleagues (2007) recently reported rates of PBDE elimination from nursing
mothers; this is the first study to measure PBDE depuration in mothers during
lactation. Depuration was examined by measuring PBDE concentrations in serial
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breast milk samples from two groups (short-term and long-term) of first-time
nursing mothers. The short-term group (n = 9) collected seven samples at fixed
intervals from weeks 4 to 24. The long-term group (n = 9) collected initial
samples 1 to 6 weeks after birth, and final samples 18 to > 85 weeks later.
Additionally, two more groups of mothers collected samples 3 to 28 days after
birth and 29 to 56 days after birth to examine depuration rates early in iactation.
Patterns of mean PBDE ievels in serial breast milk samples were
examined over time. The predominant congener was BDE-47 and it correlated
with the total sum of PBDEs. Therefore, BDE-47 was used to show depuration
rates. Hooper and colleagues (2007) concluded that body burden of PBDEs
were lowered by lactation; however, depuration of PBDEs by lactation is siow,
averaging 1 to 3% per month or a 12 to 18% decrease after 6 months of
breastfeeding. Depuration rates of PBDEs in the earlier stages of lactation were
not higher as compared to later in iactation. It was suggested that infant intake of
PBDEs for a second child would not be markedly lower as compared to the first
child.
Infant Intake of PBDEs
According to Loveiady et al. (2002), breast milk biomonitoring data should
not be used to assess infant exposure if oniy one milk sample has been collected
at one time point because environmentai chemical concentrations can decrease
over the course of lactation. Four breast milk biomonitoring studies have
reported the estimated daily intake of PBDEs for infants (Chao et al., 2007;
Johnson-Restrepo et al., 2007; Main et al., 2007; Meironyté et al., 1999). Breast
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milk biomonitoring studies tend to focus on estimating body burden of the
mother, rather than assessing infant exposure, which provides an explanation for
the limited number of studies that are available documenting an infant’s intake of
PBDEs from breast milk.
Meironyté and colleagues (1999) estimated that the average daily intake
of PBDEs from pooled breast milk samples for a 5 kg infant increased from 0.3
ng/kg body weight in 1972 to 16.8 ng/kg body weight in 1997. More recently,
Main et al. (2007) estimated the median daily intake of PBDEs for a three-month
old infant to be 16 ng/kg body weight, which was calculated from one breast milk
sample that consisted of several small aliquots collected over successive
feedings. Chao and colleagues (2007) reported a daily intake of PBDEs for a
breastfed newborn infant to be 20.6 ng/kg body weight; however, it’s assumed
that only one 25 ml sample was collected from each mother. Based on median
PBDE concentrations in breast miik samples from Massachusetts, JohnsonRestrepo et al. (2007), estimated a one-month old infant’s intake to be 4 ng/kg
body weight for selected congeners (BDE-47, 99, and 153), but it’s not known
how many samples were collected from each participant.
At this time, additional research is needed to estimate infant intake of
PBDEs, specificaiiy studies that coilect serial breast milk samples over time.
Estimating infant intake of PBDEs provides information on an infant’s body
burden; however, determining infant exposure to environmentai chemicals via
breastfeeding and the potentiai health implications warrants a longitudinal
research design, an assessment of prenatal exposure (usually via cord blood).

37

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

and the measurement of environmental chemicals in breast milk at several time
points during lactation (Lovelady et al., 2002).
Potential PBDE Sources of Exposure
Breast milk biomonitoring researchers have evaiuated PBDE exposure
sources through assessment questionnaires (Akutsu et ai., 2003; Bi et al., 2006;
Chao et al., 2007; ErdogruI et al., 2004; Eslami et al., 2006; Fângstrôm et al.,
2005; Ingelido et al., 2007; Jaraczewska et al., 2006; Kalantzi et al., 2004; Lind et
al., 2003; Lunder & Sharp, 2003; Main et al., 2007; Ohta et al., 2002; Schecter et
al., 2003; Schuhmacher et al., 2007; She et al., 2007; Wu et al., 2007) and one
recent study also analyzed house dust concentrations (Wu et al., 2007).
Exposure assessment questionnaires have evaluated the following: a.) dietary
intake; b.) personal characteristics (e.g. age, anthropometries, parity,
menstruation); c.) personal habits (e.g. smoking, alcohol consumption); d.)
household and work environments (e.g. presence and number of eiectronics); e.)
place of residence (e.g. urban or industrial zones); and/or f.) season in which
infant was breastfed. Only a few studies have found significant relationships
between PBDE levels in breast miik and exposure sources. The most significant
relationships that have been documented are with house dust concentrations,
dietary intake and smoking.
Wu and colleagues (2007) found a strong and positive correiation between
PBDE concentrations in breast miik and house dust suggesting that the indoor
home environment plays an important role in PBDE exposure. Twelve
participants out of 40 agreed to dust sampiing in this study, and those
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participants with high PBDE dust concentrations had PBDE levels in breast milk
that were 2.6 times higher as compared to those homes with lower dust
concentrations.
In the same study, associations were also found between PBDE
concentrations in breast milk and dairy intake as well as total meat consumption
(Wu et al., 2007). The strongest association was found with dairy intake, which
suggested a 3.6-fold increase in PBDE levels per daily ounce of dairy fat
consumed. In addition to dairy intake, total meat consumption was also
associated with an increase in PBDE levels per serving. For every 2 to 3 ounces
of meat consumed, there was a 1.5-fold increase in PBDE levels. Other dietary
factors, such as total fish consumption, were not significantly associated with
PBDE levels in breast milk. However, in a small sampling of women from Japan,
PBDE concentrations were significantly elevated with a higher frequency of fish
consumption (every day) as compared to PBDE concentrations of women with a
relatively low fish consumption (1 to 2 days per week) (Ohta et al., 2002). Few
other studies have detected an association between PBDE levels in breast milk
and dietary factors, but personal habits have indicated a relationship.
Lind and colleagues (2003) found a significant relationship between
smoking and PBDE levels in breast milk. Even though the square of the
correlation coefficient was low, it increased from 10 to 17% after the addition of
smokers into the multiple regression model. Research continues to further
examine PBDE exposure sources to better understand what contributes to
human exposure.
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Advancing Breast Milk Biomonitorina Research
In the U.S., four peer-reviewed research studies have reported PBDE
levels in breast milk (Table 2). One study in the U.S. has reported rates of PBDE
elimination over time in a small sample of nursing mothers from California
(Hooper et al., 2007), and one has demonstrated relationships between PBDE
levels in breast milk and house dust, dairy intake, and meat intake (Wu et al.,
2007). Given the limited number of PBDE breast milk biomonitoring studies in
the U.S. and no studies to date from the state of New Hampshire, there is a need
to further document PBDE levels in humans, examine PBDE levels in breast milk
over time, and further evaluate potential sources of PBDE exposure, all of which
will be addressed in this research.
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CHAPTER III
MATERIALS & METHODS

communication pamphlet
One of the primary research objectives of this project was to develop an
informative, yet reassuring tool to educate potential subjects about the research.
Indeed, the intent of the research was not to undermine breastfeeding and scare
mothers away from nursing their infants.
To address this objective, an undergraduate independent study student,
who worked with the Carey Laboratory in the spring 2005 semester, assisted with
developing the communication pamphlet. The format of the pamphlet contained
short sections about the research study, body burden, what PBDEs are and
where they come from, why we are measuring PBDEs, and the importance of
breastfeeding. The final draft of the communication pamphlet also included a
section on “frequently asked questions”.
As part of the communication pamphlet development phase, we
collaborated with a health promotion advisor from the New Hampshire
Department of Health and Human Services (NH DHHS), a faculty member from
the Family Research Laboratory at the University of New Hampshire (UNH), the
New Hampshire Breastfeeding Task Force and a focus group of women from the
community. This collaboration provided us with valuable feedback on the content
of the pamphlet, language and our overall research design.
41
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Our first collaborative meeting was in March 2005 with the NH DHHS
health promotion advisor and the faculty member from the Family Research
Laboratory. Their primary recommendations were to eliminate the technical
language in order to decrease the reading level from 12*^ grade to 8*^ grade. In
addition, they recommended that the pamphlet be visually appealing and be
reassigned a less scientific name. The project’s secondary name became Steps
to a Healthy Future.
Our second meeting was in April 2005 with 20 members of the New
Hampshire Breastfeeding Task Force. The members of the Task Force are
primarily registered nurses and registered dietitians who are lactation specialists.
This meeting provided valuable input regarding appropriate breastfeeding
language and further elimination of technical wording. During this meeting,
members of the Task Force also provided helpful suggestions on our research
design including sample collection time, sample size, breastfeeding support to
participants and information on personal use vs. rental breast pumps.
Our third meeting was in May 2005 when we conducted a six person, one
hour focus group to assess the content of the pamphlet. We recruited women
from the UNH campus who were currently breastfeeding or had breastfed their
child within the last two years. We provided background information on the
study, reviewed each section of the communication pamphlet, and collected
verbal and written feedback from the focus group participants. The verbal
feedback emphasized refinement of language to further improve the readability of
the communication pamphlet. The written feedback was collected by having
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participants complete an anonymous 10-question survey (Appendix A) about the
content and clarity of the pamphlet at the end of the focus group session. The
written feedback directed us to emphasize the health effects of PBDEs,
participant time commitment and what will happen with the final results of the
study.
The communication pamphlet was completed in August of 2005. The
final format was an eight page pamphlet with readability statistics at the 5“^ grade
reading level (Appendix B). Approximately 1500 copies of the pamphlet were
distributed to lactation consultants and placed in eight locations around the
Seacoast area of New Hampshire (Dover Pediatrics, Exeter Hospital Family
Center, Harbour Women’s Health, Lamprey Health Care, Portsmouth Regional
Hospital, Rochester Women, Infants & Children Clinic, Seacoast Area La Leche
League, and Wentworth Douglass Hospital) for subject recruitment.
recruitment
Participants were recruited from the Seacoast region of New Hampshire
from November 2005 to July 2006. Recruitment was accomplished by lactation
consultants from three area hospitals - Exeter Hospital, Portsmouth Regional
Hospital, and Wentworth Douglass Hospital -, distribution of the communication
pamphlet, and word of mouth. The study protocol was approved by the UNH
Institutional Review Board (IRB # 3433) and approval from each hospital was
obtained prior to working with the lactation consultants. I attended monthly
breastfeeding classes at each of the hospitals to provide research study
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information and the communication pamphlet to pregnant women. The lactation
consultants also provided the communication pamphlet to postpartum women
prior to their discharge from the hospital. In addition, the pamphlet was
distributed to outpatient health care clinics.
participants
Women, ages to 22 to 40 from the Seacoast region of New Hampshire,
who were in the early stages of lactation (less than 2 weeks) or in their last
trimester of pregnancy and planned to breastfeed for at least the first threemonths postpartum, were eligible for the study. Participant eligibility criteria also
included delivering a full-term, healthy infant and planning to provide greater than
80% of breast milk as the primary source of nutrition for the first three-months.
To show our appreciation for participation in the study, enrolled subjects
were provided with an Ameda Purely Yours® personal use electric breast pump
and kit. Each kit contained one personal use electric breast pump with a dual
hygienic milk collection system, six 4-ounce clear, plastic bottles, a power
adapter, an insulated tote with cooler pack, and a carry bag. Participants had the
opportunity to talk with a professional lactation consultant during their enrollment
in the study.
study design, procedures and analytical methods
Participants were asked to visit with researchers on four occasions over a
three-month period for a total of approximately four hours (Figure 1).

'

Researchers could meet with participants at their homes or at UNH.
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Last Trimester

First 3-monttis postpartum
3
weeks

Recruitment

4
weeks

8
weeks

12

weeks

Recruitment

Visit
1

Visit
2

Visit

3

Visit
4

Note:

Visit 1: Study orientation, obtained consent, administered Maternai Characteristics Survey & Food Frequency
Questionnaire #1, measured body weight, provided personal useeiectricbreast pump and kit
Visit 2: Sample pick-up (1 or 3 samples),
provided Environment Survey
Visit 3: Sample pick-up (1 or 3 samples),
retrieved Environment Survey
Visit 4: Sample pick-up (1 or 3 samples),
administered Food Frequency Questionnaire #2,measured body weight,
study debriefing

Figure 1. Study design from recruitment to visit 4.

The first visit occurred at three weeks postpartum. During the first visit,
participants were oriented to the study’s purpose and design, compieted a food
frequency questionnaire and a maternai characteristics survey, were weighed on
a Heaith o meter® mechanical floor-level scale, and signed a UNH IRB subject
consent form (Appendix C). Participants received verbai and written instruction
on breast milk expression via the personal use eiectric breast pump, sample
collection procedure and sam ple storage (A ppendix D ). Participants also

received four ounce amber glass storage containers with Teflon fitted lids, a
pumping schedule (Appendix E) for the first month coiiection period and their
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personal use breast pump.
The second visit occurred at four weeks postpartum. Participants
surrendered the first month’s samples, received additional four ounce amber
glass storage containers, met with the researchers to answer any questions and
set up a pumping schedule for the second month collection period. During the
second visit, participants were asked to complete an environmental survey on
their own and mail back to UNH in a self-addressed stamped envelope or return
it to the researchers at the third visit.
The third visit occurred at eight weeks postpartum. Participants
surrendered the second month’s samples, provided the completed environmental
survey, received additional four ounce amber glass storage containers, met with
the researchers to answer any questions and set up the final pumping schedule
for the third month collection period. The fourth visit occurred at 12 weeks
postpartum, when participants surrendered the third month’s samples, had their
body weight measured, completed a food frequency questionnaire and received
study debriefing.
The first seventeen participants were asked for a maximum of nine breast
milk samples during the first three-months of breastfeeding. Each participant
provided up to three samples at the end of their first, second, and third month of
breastfeeding for evaluation of day-to-day and month-to-month variation in PBDE
levels. To evaluate day-to-day variation in PBDE levels, participants provided
one sample from three successive mornings at the end of months one, two and
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three. Day-to-day variation was analyzed on the first five participants. Month-tomonth variation in PBDE levels was evaluated on ail participants by taking one
sample at the end of months one, two, and three. The first day sample was
taken for month-to-month variation from those participants who provided three
samples per month.
Breast Milk Expression and Collection
Participants used the Ameda Purely Yours® personal use electric breast
pump to collect their samples. One sample was the equivalent of one complete
expression from one breast. The collected volume of breast milk samples
differed from participant to participant based upon the mother’s milk supply. An
emphasis was placed on collecting a complete expression to ensure that hind
milk was included in the sample, which enabled us to examine lactation-specific
maternal characteristics (e.g. percent lipid content in breast milk) on whoieweight PBDE levels in breast milk

Participants were instructed to wash their

hands and breast with a mild, detergent-free soap prior to milk collection
(Appendix D). in addition, milk expression occurred between the hours of 6 a.m.
and 9 a.m. on the determined collection day with a minimum two hour time frame
since the previous feeding from that breast; this protocol standardized the
sample coiiection period to reflect the daily average lipid concentration in breast
milk. Once milk expression was compieted, participants were instructed to
detach the kit coiiection container from the pump and gently invert the sample
three to four times and transfer the milk into a labeled study container, which was
the four ounce amber glass storage container that had been detergent-washed
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and then rinsed with analytical grade solvents in the laboratory (toluene followed
by hexane). Participants completed the label (Appendix F), which included
subject number, time of last feeding as well as date and time of milk collection
and then placed the sample into the refrigerator.
Breast Milk Sample Handling and Storage
Samples were either picked up by the researchers or transported by the
participants to UNH within 72 hours of expression. Samples were transported in
a cooler with cooler packs or on ice to keep the samples cold. Upon arrival to
UNH, the volume was measured and logged into a participant inventory
spreadsheet (Appendix G), each sample was gently inverted three to four times,
and an aliquot was transferred into a two ounce amber glass jar with a Teflon
fitted lid. Ail samples were placed into the freezer (-20° C) until shipment.
Frozen samples were shipped on three separate occasions. Each two
ounce amber glass jar was wrapped in a plastic storage bag and placed in their
original boxes. Boxes were placed in a Styrofoam shipping cooler, packed with
dry ice, and shipped overnight to Dr. Janice K. Huwe’s Biosciences Research
Laboratory of the U.S. Department of Agriculture in Fargo, North Dakota. Upon
arrival, samples were placed in the freezer (-65° C) until analysis.
Breast Milk Sample Anaivsis
Analysis of each breast milk sample was performed using previously
published methodology (Huwe & Smith, 2007; Ryan, 1991; U.S. ERA, 2003). Dr.
Huwe’s laboratory quantified 46 PBDE congeners in 150 breast milk samples by
isotope dilution method.
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Sample Preparation. Sample preparation required: 1). extraction of fat
components and native PBDE analytes from milk samples, 2). determination of
fat content in milk samples, and 3). cleanup of the samples via column
chromatography.
Prior to the first step (extraction), a mixture of 10 ^^C-PBDE recovery
standards (BDE-28, 47, 99,100,153, 154,183,197, 207, and 209) were added
to each sample; the addition of the recovery standards quantitates precision and
recovery of the analytical method. Selection of the recovery standards was
based on the most common congeners that are typically detected in samples and
standards represented each homolog group (tri, tetra, penta, hexa, hepta, octa,
nona, and deca). All standards were obtained from either Wellington
Laboratories (Guelph, Ontario, Canada) or Cambridge isotope Laboratories
(Andover, MA). The following amounts of each standard were added: 2 ng for
BDE-28, BDE-47, BDE-99, BDE-100, BDE-153, BDE-154, and BDE-183; 4 ng for
BDE-197 and BDE-207; and 20 ng for BDE-209 (J.K. Huwe, personal
communication, July 20, 2007).
The purpose of the first step was to liberate the fat components and native
PBDE analytes from protein and water soluble substances. This step required
approximately 2 hours per set of samples. One set of samples was 3 breast milk
samples from a participant and a method blank or method spike. Each breast
milk sample (5, 7, or 15 ml) was placed in a Teflon bottle and deproteinated with
potassium oxalate (20 mg/g milk) (Ryan, 1991). An equal volume of breast milk
to ethanol was used to disrupt the fat globule membranes. The breast milk-
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ethanol mixture was extracted with an equai volume of diethyl ethenhexane (2:3,
v:v). Once the layers were separated, the upper organic phases were then
transferred into large tubes and concentrated on a TurboVap™ concentrator
(Zymark Corporation, Hopkinton, MA). The remaining solid and aqueous phases
were extracted with a volume of hexane that was equai to the original aliquot
volume and centrifuged for 20 minutes. The organic phases were combined with
any remaining etherhexane and further concentrated to small volumes on the
TurboVap™: the tube sides were rinsed with hexane while concentrating.
Hexane was added to each concentrate; the diluted concentrate was transferred
to small Teflon bottles (4 x 10 ml of hexane). The extract was washed with
distilled water and dried over 20 grams of anhydrous sodium sulfate.
The second step, determining the percent lipid content of the milk samples
gravimetrically, was done by evaporating and weighing aliquots of the extracted
samples from step one (10 out of 100 mi). This allows us to report PBDE levels
on a lipid-adjusted basis, and as needed, on à whole-weight basis. Using the
lipid-adjusted basis allows for normalizing concentrations of PBDEs both within
samples from one mother and among samples from many mothers (Needham &
Wang, 2002). Additionally, these lipid-adjusted concentrations could be used for
infant intake estimates.
Once the lipid weight was determined for each milk sample, the remaining
extract was concentrated to 12 ml of hexane, in preparation for the column
cleanup procedure. Column cleanup is a critical step in sample preparation as it
separates the lipids and native analytes from other lipid soluble components in
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the milk sample, such as steroids and vitamins (J.K. Huwe, personal
communication, August 1, 2007).
Each sample was chromatographed on disposable triphasic silica gel and
basic aiumina oxide columns. These columns were used to remove high
molecular weight non-polar and polar interferences (U.S. EPA, 2003). Ail
chromatography was performed using an automated Power Prep instrument
(Fluid Management Systems, Waltham, MA).
The column chromatography procedure, from the silica column to the
alumina oxide column to the collection tube, occurred in one uninterrupted
process over a 2 hour period (J.K. Huwe, personal communication, August 1,
2007). The PBDEs were eluted from the silica column on to the alumina column
with hexane. The aiumina column was washed with 2% methylene chloride in
hexane to remove interfering compounds and then PBDEs were eluted from the
alumina oxide column to the collection tube in 125 ml of methlylene
chloride/hexane (50/50) and were reduced in volume on the TurboVap™. The
small volume (0.2 ml) remaining in the TurboVap™ tube was transferred to an
amber vial containing dodecane (15 pi) as a keeper solvent and evaporated by a
steady flow of nitrogen. Three ^^C-PBDE injection standards (BDE-77,139 and
205) were added to the final volume (20 pi). The following amounts of each
injection standard were added to the final volume: 1.5 ng for BDE-77 and BDE139, and 3 ng for BDE-205. The injection standards were added prior to high
resolution gas chromatography (GC) and provided adequate coverage of the
entire GC elution range; the injection standards quantitated the recovery
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standards by serving as the internai standard.
Sample Anaivsis. Samples were analyzed for PBDEs on a Hewlett
Packard 5890 GC coupled to a VG Autospec mass spectrometer (Micromass,
Beveriy, MA). The GC was the analytical instrument for separating the PBDEs.
Cooi-on-coiumn injection was used to introduce 2 pi of each sample into the GC;
this injection system was used to minimize thermal degradation of BDE-209. The
sample underwent instantaneous volatilization and was transported by the carrier
gas (helium) through the capillary column. Separation of PBDEs was achieved
on the capillary column using a 30 m DB-5ms column (0.25 mm internal
diameter, 0.25 pm film thickness) with the temperature programmed from 120°C
(2 min initial hold) to 300°C at 10°C /min then held for 28 min and the carrier gas
flow was pressure programmed from 20 psi (2 min initial hold) to 10 psi at 20
psi/min then to 55 psi at 2 psi/min and held for 15 min (Huwe & Smith, 2007).
isolated PBDEs eluted from the GC column and were then captured by the mass
spectrometer.
The mass spectrometer (MS) was run at a resolution of 5000 in the
selective ion monitoring mode to detect ion pairs (Huwe & Smith, 2007).
Selective ion monitoring was used for its sensitivity with complex samples since
only the selected masses were detected and plotted. The MS captured the
isolated PBDEs as they eluted off of the GC column and ionized them into
electrically charged particles that were transported by an electromagnetic field to
the mass analyzer. The mass analyzer then sorted the ions according to their
mass-to-charge ratio. The sorted ions were then detected and the signal was

52

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

sent to the data system where it was recorded in the format of a mass-to-charge
ratio spectrum (McMaster & McMaster, 1998).
For identification and quantitation of PBDEs, the ratio of the paired ions
was required to be within 15% of theoretical and the native congener required to
co-eiute within 1 sec of the ^^C-labeled surrogate or within 4 sec of the
corresponding standard in the curve when no ^^C-labeled surrogate was present
(Huwe & Smith, 2007). A six point standard curve was employed to cover the full
range of PBDE concentrations.
Limit of Detection. The limit of detection (LOD) is the lowest concentration
of a chemical that can be measured by the analytical method (Needham & Wang,
2002). The LODs for each congener were established from method blanks. A
method-blank or method spike (precision and recovery check) was run every
fourth sample. The detection limit was set at three times the standard deviation
of the blanks; all values below the detection limit were treated as nondetects (nd)
and were set to zero. Data were blank subtracted because method blanks
contained detectable amounts of native analytes (J.K. Huwe, personal
communication, August 1, 2006).
Quaiitv Assurance/Quaiitv Control. The recoveries of all ^^C-surrogates
were between 25% and 150%; all native congeners were recovery corrected.
Using spiked samples, the reported native analytes showed recovery and
precision to be within 20% of the true value. The Huwe laboratory has
successfully participated in an international inter-lab comparison study conducted
by the Norwegian Public Health and scored within +/- 30% on breast milk
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analysis of the major PBDEs (J. K. Huwe, personal communication, August 1,
2006).
Laboratory Techniques. Aii glassware was washed by hand with
detergent and rinsed with tap water, distilled water, and analytical grade solvents
prior to use. Sample preparation steps were performed in opaque containers.
To minimize exposure to light, samples were either covered or refrigerated
between steps.
stability study
There were two unfortunate experiences with some of the breast milk
samples during the research study. The first occurred at UNH when the -20°C
freezer stopped working at the end of June 2006. The alarm failed to sound and
the breast milk samples thawed before the problem was noticed. The second
incidence occurred at Dr. Huwe’s laboratory when a shipment of samples was
accidentally left in the shipping box on dry ice for several days at the beginning of
March 2007.
There was a surplus of nine breast milk samples that did not experience
either of these incidents. These nine samples underwent a replicated
temperature experience (four for the first incident and five for the second) as we
wanted confirmation that lipid degradation was not accelerated during the thaw.
Data showed that, on average, there was a 4.4% decrease in the percent lipid
content of the nine samples, which was indicative of negligible changes. Dr.
Huwe then analyzed the PBDE concentrations of three samples (one sample
from incident #1 and two samples from incident #2). The average percent
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change of the sum of the measured PBDE levels in the three samples was a
15% increase. The congener profiles for the three samples were further
examined for differences in their levels; the percent change for the 4 major
congeners that represented 73% of the total sum included: a 13% increase in
BDE-47, a 17% increase in BDE-153, a 22% increase in BDE-99, and a 38%
increase in BDE-100. The stability data is presented in Appendix H. Based on
the stability experiment, it was concluded that the temperature incidents had a
minimal effect on the lipid content and PBDE concentrations in breast milk.
survey development and administration
A total of four surveys were compieted by the participants during their
three-month commitment in the study: A Maternal Characteristics Survey, two
Food Frequency Questionnaires, and a Maternal Environment Survey.
Maternal Characteristics Survey
i administered the Maternal Characteristics Survey during visit one
(Appendix I). The intent of this survey was to examine potential relationships
between PBDE levels in breast milk and personal characteristics such as
demographics, measured body weight, calculated body mass index (BMI),
breastfeeding history, physical activity level, health history and smoking status.
During the development phase of the Maternal Characteristics Survey, feedback
was obtained from academic scholars whose expertise was in epidemiology and
sociology. Suggestions focused on wording of survey questions to ensure
readability and clarity. It was also recommended that we collect demographic
information, particularly on education and income. This would permit our
55
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findings to be compared to statewide data from the New Hampshire Department
of Health and Human Services (2002).
Food Frequency Questionnaire
The Food Frequency Questionnaire was administered twice during the
study, as pregnancy and the postpartum period can cause changes in dietary
behavior (Devine et ai., 2000; George et al., 2005). Nutrient data was collected
using a food frequency questionnaire developed by the Nutrition Assessment.
Shared Resource (NASR) of Fred Hutchinson Cancer Research Center
(FHCRC) (Patterson et ai., 1999) (Appendix J). Dietary intake during the iast
trimester of pregnancy was evaluated at visit one, and dietary intake during the
three-month postpartum period was evaluated at visit four. I assisted participants
in completing the questionnaire by asking each question and filling out the form
while the participant foliowed along with their own copy. I explained the format of
the questionnaire and used food models to assist participants with estimating
portion sizes. All completed food frequency questionnaires were sent to FHCRC
for a comprehensive analysis of 125 nutrients.
The nutrient data that was extracted from the FHCRC analysis included
the following: total calories; grams of carbohydrate, total fiber, water-soluble
fiber, insoluble fiber, protein, vegetable protein, animal protein, total fat, saturated
fat, polyunsaturated fat, monounsaturated fat, trans-tatty acids, and alcohol; and
milligrams of cholesterol. In addition, 27 questions were selected to quantify the
frequency and amount of meat, fish, egg, dairy product, fruit, vegetable, and
fat/oil consumption.

56

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

Maternal Environment Survey
A Maternal Environment Survey was completed by each participant on
their own time in their home (Appendix K). The intent of the Maternai
Environment Survey was to evaluate for associations between PBDE levels in
breast fniik and living/occupational environment. The survey contained questions
on residence history, subject occupation, details of transportation mode,
household appliances, furniture, electronics, and other PBDE-containing
products. Dr. Tom Webster (personal communication, July 26, 2005) from
Boston University School of Public Health shared his survey from the Greater
Boston PBDE Body Burden Project, which assisted in developing the content of
our Maternal Environment Survey.
A UNH epidemiologist provided guidance during the development phase
of the Maternal Environment Survey. The primary suggestion was to validate the
survey, it was beyond the scope of this research to implement sensitivity and
specificity testing on the survey, but feasible to conduct a piiot-test with a similar
population of participants to optimize content, readability and range of responses.
The Maternal Environment Survey underwent a pilot-test with women who
were currently lactating or who had breastfed within the past year. A total of 19
surveys were distributed to New Hampshire women during the fall of 2005.
Women were asked to complete the Environment Survey in their home, and fill
out a feedback questionnaire (Appendix L). Out of 19 surveys, 16 (84%) surveys
were completed and returned. Range of responses was reviewed on all
completed surveys. This provided valuable insight on the readability, clarity and
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interpretation of survey questions. Completed surveys were evaluated for
missing data and if information was filled out correctly. A wide range of
responses for one question on stereo equipment led us to re-word this question
for improved clarity.
in addition to filling out the survey for the piiot-test, women completed a
feedback questionnaire in which additional comments on survey questions,
length of time to complete the survey and suggestions for improvement were
recorded. Comments from participants on the feedback questionnaire provided
additional insight on survey questions that required refinement of language and
response options. The average length of time to complete the survey was 15
minutes, and participants agreed that completing the survey in the home was
helpful. Overall, women found the survey easy to follow with minor suggestions
for improvement. The preliminary work for the Maternal Environment Survey
provided valuable feedback, and the necessary changes were implemented prior
to recruitment.
statistical anaivsis
PBDE data was log-transformed prior to statistical analyses, and normality
of PBDE concentrations was assessed using normal probability plots and
Shapiro-Wiik’s test. PBDE concentrations in breast milk (monthly means and
three-month means) were evaluated for associations with dietary habits (last
trimester and postpartum), maternal characteristics, and living/occupational
environments. Potential associations were explored using scatter plots,
correlation analysis, and backward regression. Differences in dietary intake from
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the last trimester and three-month postpartum period were evaluated using
paired samples t-test. Differences in mean PBDE values over time and mean
percent lipid levels from months one, two, and three were evaluated using
repeated-measures analysis of variance. Regression analysis was used to
evaluate the relationship between PBDE levels in breast milk and maternal
characteristics, living/occupational environments, and dietary intake. Potential
confounders were evaluated for associations with exposure variables, and by
examining the changes in the |3 coefficients when excluded variables were added
back into the reduced model. If the addition of the excluded variable caused a
change in the (3 coefficient by at least 10%, the variable remained in the model
(Friis & Sellers, 2004; Sjodin et al., 2008). Regression coefficients were
converted back to the original scale, which provides the fold change (or percent
increase or decrease) in breast milk PBDE concentrations per unit of exposure.
Statistical analyses were performed using the Statistical Package for Social
Science (SPSS) 13.0 version with statistical significance set at 0.05.
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CHAPTER IV

MANUSCRIPT 1: BIOMONITORING BREAST MILK POLYBROMINATED
DIPHENYL ETHERS AS A FUNCTION OF ENVIRONMENT, DIETARY INTAKE,
AND DEMOGRAPHICS OF LACTATING WOMEN IN THE SEACOAST AREA
OF NEW HAMPSHIRE
introduction
Biological monitoring, or biomonitoring is the measurement of
environmental chemicals, their metabolites, or their reaction products in the
human body, specifically through blood, urine, saliva, breast milk, adipose or
other tissue (Needham et al., 2007; U.S. DHHS, CDC, 2005). The purpose of
biomonitoring is to document, update and expand human exposure information
on environmental chemicals. The use of breast milk as a biological matrix for
biomonitoring studies can estimate environmental chemical exposure in both the
mother and breast feeding infant (Lovelady et al., 2002). Breast milk can be a
convenient and noninvasive means for estimating environmental chemical
exposures in nursing women as compared to other biological matrices (Hooper &
She, 2003); it also enables researchers to collect a biological specimen with a
high fat content (Fenton etal., 2005), which is an important consideration for
lipid-soluble environmental chemicals - particularly those that have been steadily
rising in their production, use, and presence in the environment and in humans,
such as synthetic flame retardants.
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Flame retardants are added to materials either during or after
manufacturing, in order to interfere with the combustion process (Bromine
Science and Environmentai Forum [BSEF], 2000). This interference can occur
during heating, decomposition, ignition or flame spread. Of the four major
classes of flame retardants - halogenated organic (usually brominated or
chlorinated), phosphorus-containing, nitrogen-containing, and inorganic flame
retardants, the brominated flame retardants (BFRs) are the most widely used due
to their low cost and high performance efficiency. (Birnbaum & Staskal, 2004;
BSEF, 2000). The most widely used BFRs are tetrabromobisphenol A,
hexabromo-cyclododecane, and three commercial products of polybrominated
diphenyl ethers (PBDEs) known as decabromodiphenyl ether (decaBDE),
octabromodiphenyl ether (octaBDE) and pentabromodiphenyl ether (pentaBDE)
(Birnbaum & Staskal, 2004; BSEF, 2000). The total U.S. market demand values
for pentaBDE and octaBDE are expected to drop to zero because Great Lakes
Chemical Corporation, the sole U.S. manufacturer of pentaBDE and octaBDE,
discontinued production of these two commercial products at the end of 2004
(U.S. EPA, 2006).
PBDEs are non-chemically bound additives, and may contribute up to
30% by weight of foams, fabrics and plastics (Hale et al., 2003; Hooper & She,
2003). Overtime, PBDEs can diffuse out of their products, become airborne or
enter dust, and disperse into the environment and into humans. Even though the
presence of PBDEs in consumer products such as teievision sets, carpet
padding, mattresses, chair and couch foams, computers, stereos, and hair dryers
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saves lives each year in the U.S., there are concerns with its widespread use and
increasing environmental and human concentrations. Their persistent, iipidsolubie characteristics permit PBDEs to bioaccumuiate as they are released from
consumer products into the air through normal use, degradation, disposal, and
recycling. Additionai release can also occur during PBDE manufacturing and
incorporation into products (Hale et al., 2003).
Biomonitoring PBDEs through breast milk has enabled researchers to
document levels worldwide (Akutsu et ai., 2003; Bi et ai., 2006; Chao et al., 2007;
ErdogruI et al., 2004; Esiami et al., 2006; Fângstrôm et al., 2005; Gômara et al.,
2007; ingeiido et al., 2007; Jaraczewska et al., 2006; Kalantzi et al., 2004; Kazda
et al., 2004; Lind et al., 2003; Main et al., 2007; Meironyté et al., 1999; Norén &
Meironyté, 2000; Ohta et al., 2002; Ryan & Patry, 2000; Ryan et al., 2006;
Schuhmacher et al., 2007) and in the U.S. (Hooper et ai., 2007; JohnsonRestrepo et al., 2007; Lunder & Sharp, 2003; Schecter et al., 2005; Schecter et
ai., 2003; She et ai., 2007; Wu et al., 2007). One study in the U.S. has reported
rates of PBDE eiimination in a smail sampie of nursing mothers from California
(Hooper et ai., 2007). Additionaiiy, breast milk biomonitoring studies provide
information about sources of PBDE exposure.
in the U.S. a iimited number of studies have demonstrated relationships
between PBDE levels in breast miik and house dust, dairy intake, and meat
intake (Wu et al., 2007). There is a need to further document PBDE ievels in
humans, examine PBDE ieveis in breast milk overtime, and further evaluate
potential sources of PBDE exposure.
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The goal of this research was to determine the ieveis of PBDEs in breast
milk of lactating women from the Seacoast region of New Hampshire and to
examine potential relationships between breast miik PBDE levels and stage of
lactation, maternai characteristics, living environment and dietary intake.
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materials & methods
Participants were recruited from the Seacoast region of New Hampshire
from November 2005 to July 2006. Recruitment was accomplished by lactation
consultants from three area hospitals, distribution of a communication pamphlet,
and word of mouth. Women, ages to 22 to 40 from the Seacoast region of New
Hampshire, who were in the early stages of lactation (less than 2 weeks) or in
their last trimester of pregnancy and planned to breastfeed for at least the first
three-months postpartum, were eligible for the study. Participant eligibility criteria
also included delivering a full-term, healthy infant and planning to provide greater
than 80% of breast milk as the primary source of nutrition for the first threemonths. The study protocol was approved by the University of New Hampshire
(UNH) Institutional Review Board (IRB # 3433) and approval from each hospital
was obtained prior to working with the lactation consultants. All participants
provided informed consent prior to their enrollment into the study.
Studv Design
Participants were asked to visit with researchers on four occasions over a
three-month period for a total of approximately four hours (Figure 1).
Researchers could meet with participants in their homes or at UNH. To show our
appreciation for participation in the study, enrolled subjects were provided with
an Ameda Purely Yours® personal use electric breast pump and kit. Participants
had the opportunity to talk with a professional lactation consultant during their
enrollment in the study.
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Visit
1
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Note:
Visit 1: Study orientation, obtained consent, administered Maternal Characteristics Survey & Food Frequency
Questionnaire #1, measured body weight, provided personal use electric breastpump and kit
Visit 2: Sample pick-up (1
or 3 samples),
provided Environment Survey
Visit 3: Sample pick-up (1
or 3 samples),
retrieved Environment Survey
Visit 4: Sample pick-up (1
or 3 sarrples),
administered Food Frequency Questionnaire #2,measured body weight,
study debriefing

Figure 1. Study design from recruitment to visit 4.

Survevs
A total of four surveys were completed by the participants during their
three-month commitment in the study: A Maternal Characteristics Survey, two
Food Frequency Questionnaires, and a Maternal Environment Survey. All
participants were interviewed in person for each survey with the exception of the
Maternal Environment Survey. The Maternal Characteristics Survey examined
potential relationships between PBDE levels in breast milk and personal
characteristics such as demographics, measured body weight, calculated body
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mass index (BMI), breastfeeding history, physical activity level, health history and
smoking status.
The Food Frequency Questionnaire, developed by the Nutrition
Assessment Shared Resource (NASR) of Fred Hutchinson Cancer Research
Center (FHCRC) (Patterson et al., 1999) was administered twice during the
study - at the beginning to assess dietary intake during the last trimester and at
the end to assess dietary intake during the first three-months postpartum. The
two time periods were assessed as pregnancy and the postpartum period can
cause changes in dietary behavior (Devine et al., 2000; George et al., 2005). We
worked with participants by completing the questionnaire with them on both
occasions, and showed food models to assist in estimating portion sizes. All
completed food frequency questionnaires were sent to FHCRC for a
comprehensive analysis of 125 nutrients. The nutrient data that was extracted
from the FHCRC analysis included the following: total calories; grams of
carbohydrate, total fiber, water-soluble fiber, insoluble fiber, protein, vegetable
protein, animal protein, total fat, saturated fat, polyunsaturated fat,
monounsaturated fat, frans-fatty acids, and alcohol; and milligrams of cholesterol.
In addition, 27 questions were selected to quantify the frequency and amount of
meat, fish, egg, dairy product, fruit, vegetable, and fat/oil consumption.
The Maternal Environment Survey evaluated associations between PBDE
levels in breast milk and living/occupational environment. The survey contained
questions on residence history, subject occupation, details of transportation
mode, household appliances, furniture, electronics, and other PBDE-containing
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products. Prior to recruitment, the Maternal Environment Survey underwent a
pilot-test with a similar population of participants to optimize content, readability
and range of responses.
Breast Milk Sampling
The first seventeen participants were asked for a maximum of nine breast
milk samples during the first three-months of breastfeeding. To evaluate day-today variation in PBDE levels, participants provided one sample from three
successive mornings at the end of months one, two, and three. Day-to-day
variation was analyzed on the first five participants. Month-to-month variation in
PBDE levels was evaluated on all participants by taking one sample at the end of
months one, two, and three. The first day sample was taken for month-to-month
variation from those participants who provided three samples per month.
Participants used the Ameda Purely Yours® personal use electric breast
pump to collect their samples. One sample was the equivalent of one complete
expression from one breast. The collected volume of breast milk samples
differed from participant to participant based upon the mother’s milk supply. An
emphasis was placed on collecting a complete expression to ensure that hind
milk was included in the sample, which enabled us to examine lactation-specific
maternal characteristics (e.g. percent lipid content in breast milk) on wholeweight PBDE levels in breast milk. In addition, milk expression occurred
between the hours of 6 a.m. and 9 a.m. on the determined collection day with a
minimum two hour time frame since the previous feeding from that breast; this
protocol standardized the sample collection period to reflect the daily average
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lipid concentration in breast milk. Once milk expression was completed,
participants were instructed to detach the kit collection container from the pump
and gently invert the sample three to four times and transfer the milk into a
labeled study container, which was a four ounce amber glass storage container
that had been detergent-washed and then rinsed with analytical grade solvents
(toluene followed by hexane). Participants labeled the amber glass storage
container and placed the sample into the refrigerator.
Samples were either picked up by the researchers or transported to UNH
within 72 hours of expression. Samples were transported in a cooler with cooler
packs or on ice to keep the samples cold. Upon arrival to UNH, the volume was
measured, each sample was gently inverted three to four times, and an aliquot
was transferred into a two ounce amber glass jar with a Teflon fitted lid. All
samples were placed into the freezer (-20° C) until shipment.
Analvtical Methods
Frozen samples were shipped overnight to the Biosciences Research
Laboratory of the U.S. Department of Agriculture in Fargo, North Dakota. Upon
arrival, samples were placed in the freezer (-65° C) until analysis. Analysis of
each breast milk sample was performed using previously published methodology
(Huwe & Smith, 2007; Ryan, 1991; U.S. ERA, 2003). Forty-six PBDE congeners
in 150 breast milk samples were measured by isotope dilution method.
Prior to extraction, a mixture of 10 ^^C-PBDE recovery standards (BDE-28,
47, 99,100, 153,154,183, 197, 207, and 209) were added to each sample. All
standards were obtained from either Wellington Laboratories (Guelph, Ontario,

68

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

Canada) or Cambridge Isotope Laboratories (Andover, MA). Each breast milk
sample (5, 7, or 15 ml) was deproteinated with potassium oxalate (20 mg/g milk).
An equal volume of breast milk to ethanol was used to disrupt the fat globule
membranes. The breast milk-ethanol mixture was extracted with an equal
volume of diethyl ether:hexane (2:3, v:v). Once the layers were separated, the
upper organic phases were then transferred into large tubes and concentrated on
a TurboVap™ concentrator (Zymark Corporation, Hopkinton, MA). The final
extract was washed with distilled water and dried over 20 grams of anhydrous
sodium sulfate. After solvent evaporation, the lipid content of the milk samples
was determined gravimetrically. Once the lipid weight was determined for each
milk sample, the remaining extract was concentrated to 12 ml of hexane, in
preparation for the column cleanup procedure.
Each sample was chromatographed on disposable triphasic silica gel and
basic alumina oxide columns. All chromatography was performed using an
automated Power Prep instrument (Fluid Management Systems, Waltham, MA).
The final volume (0.2 ml) was transferred to an amber vial containing dodecane
(15 pi) as a keeper solvent and evaporated by a steady flow of nitrogen. Three
^^C-PBDE injection standards (BDE-77,139 and 205) were added to the final
volume (20 pi) prior to high resolution gas chromatography (GC).
Samples were analyzed for PBDEs on a Hewlett Packard 5890 GC
coupled to a VG Autospec mass spectrometer (Micromass, Beverly, MA). Coolon-column injection was used to introduce 2 pi of each sample into the GC.
Separation of PBDEs was achieved on the capillary column using a 30 m DB-
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Sms column (0.25 mm internal diameter, 0.25 pm film thickness) with the
temperature programmed from 120°C (2 min initial hold) to 300“C at 10°C /min
then held for 28 min and the carrier gas flow was pressure programmed from 20
psi (2 min initial hold) to 10 psi at 20 psi/min then to 55 psi at 2 psi/min and held
for 15 min. Isolated PBDEs eluted from the GC column and were then captured
by the mass spectrometer. The mass spectrometer (MS) was run at a resolution
of 5000 in the selective ion monitoring mode to detect ion pairs (Huwe & Smith,
2007).
For identification and quantitation of PBDEs, the ratio of the paired ions
was required to be within 15% of theoretical and the native congener required to
co-elute within 1 sec of the ^^C-labeled surrogate or within 4 sec of the
corresponding standard in the curve when no ^^C-labeled surrogate was present
(Huwe & Smith, 2007). A six point standard curve was employed to cover the full
range of PBDE concentrations.
The limit of detection (LCD) for each congener was established from
method blanks. A method blank or method spike (precision and recovery check)
was run every fourth sample. The detection limit was set at three times the
standard deviation of the blanks; all values below the detection limit were treated
as non-detects (nd) and were set to zero. Data were blank subtracted because
method blanks contained detectable amounts of native analytes (J.K. Huwe,
/

personal communication, August 1, 2006).
The recoveries of all ^^C-surrogates were between 25% and 150%; all
native congeners were recovery corrected. Using spiked samples, the reported

70

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

native analytes showed recovery and precision to be within 20% of the true
value. The Huwe laboratory has successfully participated in an international
inter-lab comparison study conducted by the Norwegian Public Health and
scored within +/- 30% on breast milk analysis of the major PBDEs (J. K. Huwe,
personal communication, August 1, 2006).
All glassware was washed by hand with detergent and rinsed with tap
water, distilled water, and analytical grade solvents prior to use. Sample
preparation steps were performed in opaque containers. To minimize exposure
to light, samples were either covered or refrigerated between steps.
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Statistical Analysis
PBDE data was log-transformed prior to statistical analyses, and normality
of PBDE concentrations was assessed using normal probability plots and
Shapiro-Wilk’s test. PBDE concentrations in breast milk (monthly means and
three-month means) were evaluated for associations with dietary habits (last
trimester and postpartum), maternal characteristics, and living/occupational
environments. Potential associations were explored using scatter plots,
correlation analysis, and backward regression. Differences in dietary intake from
the last trimester and three-month postpartum period were evaluated using
paired samples t-test. Differences in mean PBDE values over time and mean
percent lipid levels from months one, two, and three were evaluated using
repeated-measures analysis of variance. Regression analysis was used to
evaluate the relationship between PBDE levels in breast milk and maternal
characteristics, living/occupational environments, and dietary intake. Potential
confounders were evaluated for associations with exposure variables, and by
examining the changes in the‘(3 coefficients when excluded variables were added
back into the reduced model. If the addition of the excluded variable caused a
change in the (3 coefficient by at least 10%, the variable remained in the model
(Friis & Sellers, 2004; Sjodin et al., 2008). Regression coefficients were
converted back to the original scale, which provides the fold change (or percent
increase or decrease) in breast milk PBDE concentrations per unit of exposure.
Statistical analyses were performed using the Statistical Package for Social
Science (SPSS) 13.0 version with statistical significance set at 0.05.
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results
Demographic Characteristics of Participants
A total of 63 women expressed an interest in the study; however, only 42
women were eligible. Two of the 42 women were unable to participant due to
limited milk supply at the start of the study. A total of 40 women completed the
study with an average age of 31 years (range 22 to 40). Participants’ current
residential locations represented 16 different towns from the Seacoast area of
New Hampshire (Figure 2). The highest percentage (25%) of participants
resided in Dover, New Hampshire.

Note. Town locations on the map are: Milton (1 ). Somersworth (2). Rochester (3), Rolllnsfbrd (4), Dover (5). Barrington (6).
Nottingham (7). Madbury (8), Lee (9), Newmaricet{10), Epping (11), Exeter (12). Stratham (13), Hampton Falls (14), Seabrook
(15), Portsmouth (16).
*

Figure 2. Breast milk sampling locations in New Hampshire
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There was limited diversity among participants: thirty-nine out of 40 participants
were Caucasian, and 80% of participants had completed a 4-year college degree
or higher (Table 1).
Each participant visited with researchers on four occasions over a threemonth period for a total of 160 visits. Participants were provided with the option
to conduct visits in their homes or at UNH: a total of 153 visits (96%) were
conducted at participant homes and 7 visits were at UNH.
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Table 1.
Participant characteristics of study population
Characteristics

n = 40

Maternal age, years (mean, SD)

31 ±4. 5

range 22 to 40

Calculated BMI (kg/m^), start® (mean, SD)

27.3 ±4.1

range 20.8 to 35.9

Calculated BMI (kg/m^), end*’ (mean, SD)

26.5 ± 4.4

range 19.2 to 36.6

Ethnicity (%)
Caucasian
Asian

97.5
2.5

Level of Education (%)
Less than high school graduate
High school diploma or GED
Some college or technical school
College graduate, 2-year degree
College graduate, 4-year degree
Masters degree
Doctoral degree

2.5
15
2.5
42.5
32.5
5

Total Household Income (%)
Less than $20,000
$20,000 to $34,999
$35,000 to $49,000
$50,000 and higher

2.5
2.5
2.5
92.5

0

/

Smoking Status (%)
Current smoker
Ex-smoker
Lives with smoker

0
10

2.5

First time mothers (%)

77.5

Parity (years)

1.4

Exclusively breast feeding, start” (%)

87.5

Exclusively breast feeding, end* (%)

80

Vegetarians® (%)__________

12.5

Note. ®W eight measured at the start of the study which was at 2 to 3 weeks postpartum; ° W eight

measured at the end of the study which was at 12 weeks postpartum; ” Start was 2 to 3 weeks
postpartum; * End was 12 weeks postpartum; ®One vegan and 4 semi-vegetarians (2 excluded
red meat; 2 excluded red meat and poultry).

75

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

PBDE Levels in Breast Milk
PBDE levels were reported with non-detects = zero. BDE-209 levels were
widely variable due to background contamination as detected In method blanks.
The detection limit range for BDE-209 was 2.2 to 38.4 ng/g lipid (mean = 12 +/- 9
ng/g llpid). Therefore, BDE-209 was not Included In the sum of PBDEs
(XPBDE). The ^PBDE congeners found In breast milk was defined as: BDE28/33,47, 85, 99, 10^, 153, 154, and 183. BDE-47 was the predominant
congener for each month and correlated with ^PBDEs (r = 0.78 p < 0.001 ). The
contribution of BDE-47 to ^PBDEs Increased as the sum Increased (Figure 3a).
BDE-47 was correlated with BDE-28/33, BDE-85, BDE-99, BDE-100, and BDE154; however, BDE-47 was not correlated with BDE-153 and BDE-183 (Table 2).
BDE-153 was correlated with ^PBDEs (r= 0.66 p < 0.001) and BDE-100; the
contribution of BDE-153 to the ^PBDEs Increased as the sum Increased (Figure
3b). Log-transformed XPBDEs, BDE-47, and BDE-153 levels were evaluated
over time (stage of lactation) and for associations with maternal characteristics,
dietary habits, and llvlng/occupatlonal environments.

76

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

(a)
•O 4.00-

C

T = 0.78 p < 0.001

3 .0 0 -

2 .5 0 -

a t 1.60-

1.00 -

3.00

2.00

4.00

5.00

natural log sum PBDE 3-month participant means (ng/g iipid)

(b)
Q-

r = 0.66 p < 0.001

“o
2 .0 0 -

oo
o o

Oo

o>

2.00

i 3.00

4.00

5.00

natural log sum PBDE 3-month participant means (ng/g lipid)

Figures 3a and 3b: Correlations between breast milk concentrations of the
ZPBDE and BDE-47 (a) and BDE-153 (b)
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stage of Lactation and Sum of PBDEs: There was no significant
difference in mean ZPBDE levels from months one, two, and three, which was a
similar finding to other research (Table 3) (Hooper et al., 2007), thus confirming
that PBDE levels in breast milk are stable for the first three-months postpartum.
The relationship between ^PBDE levels and time did not change based on age,
BMI, or number of other prior children breastfed. The ^PBDE concentrations in
breast milk over the three-month collection period ranged from 6.5 to 166.7 ng/g
lipid. The mean for the three-month period was 35.5 ng/g with a median value of
29.7 ng/g lipid.

Table 3.
XPBDE levels in breast milk from months one, two, and three
Collection Period
n = 40

Minimum
ng/g lipid

Maximum
ng/g lipid

Mean
ng/g lipid

Median
ng/g lipid

Month 1

6.8

166.7

37.3®

28.6

Month 2

6.6

133.7

35.1®

28.1

Month 3

6.5

118.4

34.1®

32.8

Note. ®No significant differences between months 1, 2, and 3 means.
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Day-to-day variation in PBDE levais was analyzed on the first five
participants (Figure 4). A total of 45 breast milk samples (9 samples per
participant) were analyzed. The variation from day-to-day revealed that 41 out of
45 samples had less than a 20% change in the ^PBDE concentrations from day
one to day two, day two to day three, and day one to day three. The largest
variation occurred in only 2 of the 5 samples during month two, day two where
the percent change was greater than 40%. Because methodological variation
was 20% (J.K. Huwe, personal communication, June 23, 2006), it was concluded
that day-to-day variation was minimal. From this point forward, it was decided to
only collect and analyze one sample per month from each participant.

Day 1

V777\Day 2
Day 3

O) 4 0
LU

Q 30

Month

Figure 4. Mean day-to-day variation for months one, two, and three.
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stage of Lactation and Congeners. The median congener pattern of
breast milk samples from month one was 47% BDE-47, 17% BDE-153, 9% BDE100, 8% BDE-99, and 19% other congeners. The average congener pattern
from month two was 44% BDE-47, 15% BDE-153, 9% BDE-99, 7% BDE-100,
and 25% other congeners. Lastly, the average congener pattern from month
three was 38% BDE-47, 14% BDE-153, 8% BDE-99, 6% BDE-100, and 34%
other congeners. There were no significant differences in mean BDE-47, BDE153, or BDE-100 levels from months one, two, and three. The relationship
between the congener ievels and time did not change based on age, BMI, or
number of other prior children breastfed.
BDE-47 was the predominant congener in 80% of the samples, which is
similar to previously reported studies. However, BDE-153 was the predominant
congener in 20% of the participants’ samples from each month. It was also
noted that the median BDE-153 contribution to the ^PBDEs was higher as
compared to some of the previously reported breast milk biomonitoring studies in
the U.S. (15% vs. 5 to 10% of %^PBDEs) (Johnson-Restrepo et al., 2007;
Schecter et al., 2003; She et al., 2007; Wu et al., 2007).

A comparison of the

PBDE congener profiles from month-to-month is displayed in Figure 5, and
congener levels are provided in Table 4; PBDE levels in individual breast milk
samples from each month are reported in Appendix H.
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16 1
a Month 1
m Month 2
□ Month 3

BDE-28/33

BDE-47

BDE-100

BDE-99

BDE-154

BDE-85

BDE-153

BDE-183

PBDE Congeners (median levels)

Figure 5. Comparison of PBDE congener patterns in breast milk samples
(n = 40, median levels).

82

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

Table 4.

Levels of PBDEs - by congener - in breast milk samples (n = 40)
Collection Period
and
Congener

Median
ng/g lipid

Minimum
ng/g lipid

Maximum
ng/g lipid

% Detection
(DL)®

BDE-28 & 33
BDE-47
BDE-85
BDE-99
BDE-100
BDE-153
BDE-154
BDE-183

1.5
13.4
0.2
2.4
2.5
4.9
0.1
<D L

0.3
3.7
< DL
< DL
0.4
0.8
< DL
<D L

5.4
59.0
0.8
6.6
15.3
109.6
0.5
2.3

100
100
65
90
100
100
78
33

BDE-28 & 33
BDE-47
BDE-85
BDE-99
BDE-100
BDE-153
BDE-154
BDE-183

1.4
12.4
0.2
2.4
2.1
4.3
0.1
<DL

0.4
3.9
<D L
< DL
0.4
1.0
< DL
< DL

4.7
54.1
2.1
7.3
15.7
83.8
0.7
1.3

100
100
65
88
100
100
73
30

BDE-28 & 33
BDE-47
BDE-85
BDE-99
BDE-100
BDE-153
BDE-154
BDE-183

1.3
12.6
0.2
2.5
2.1
4.7
0.2
<DL

0.3
3.8
<DL
<DL
0.4
0.8
<DL
<DL

4.3
43.5
1.4
10.2
12.0
81.3
0.5
0.9

100
100
55
88
100
100
63
33

Month 1
(0.06)
(0.83)
(0.03)
(0.65)
(0.16)
(0.08)
(0.07)
(0.16)

Month 2

Month 3

Note. < DL = below the detection limit; ®the average DL values over the sample analysis time
frame in ng/g lipid.
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PBDE Levels in Breast Milk and Maternal Characteristics
Percent Lipid. The mean lipid content in breast milk for month one was
3.3% (range 1.6 to 5.0%), for month two was 3.3% (range 1.1 to 8.5%), and for
month three was 3.0% (range 0.9 to 6.8%). There was no significant difference
in mean percent lipid values from months one, two, and three. There was a
significant, positive association between XPBDE levels (ng/g milk) and percent
lipid content in breast milk samples over the three-month period (r= 0.62 p <
0.001) (Figure 6) with a similar Spearman’s correlation coefficient (r= 0.64 p <
0.001). The significant, positive observation validates reporting PBDE levels on
a lipid-adjusted basis.
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Figure 6. The association between ^PBDE levels (ng/g milk) and percent lipid
content in breast milk.
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Maternal Characteristics Survey. Some of the data from the Maternal
Characteristics survey indicated limited variability among participants, including
education, ethnicity, total household income, and health history information.
There were no associations between ^PBDE levels and age, parity, body mass
index, pre-pregnancy weight, number of other children breastfed, physical activity
level, weight lost on a diet, vegetarian status, smoking history, or the estimated
amount of supplementary formula provided to the infant during the study. Similar
findings were also seen with congener (BDE-47 and BDE-153) levels and
maternal characteristics, however, an association was seen between BDE-153
and age (r = 0.36 p = 0.02, participant three-month means). For each unit (year)
increase in age, there was a 1.1- fold change (or 10% increase) in BDE-153
(Figure 7). The association between age and BDE-153 weakened after adjusting
for change in BMI from the start of the study until the end (r = 0.36 p = 0.07).
Change in BMI was included as a confounding variable based upon its
association with age and its effect on the p coefficient (Table 5).
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r = 0.36 p = 0.02
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Figure 7. The association between BDE-153 levels in breast milk and age.

Table 5,
The effect of confounding on age
Age (Exposure)
Confounder

Spearman’s Correlation Coefficient
(p value)

Change in BMI from
start of study to end

Hote.

0.45
(p = 0.004)

Adjusted p
(95% Cl)

1.2®
(1.0,1.2)

Crude (3 was 1.1 (95% Cl = 1 .0 - 1.2).
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PBDE Levels in Breast Milk and Dietary Intake
The transition from the last trimester of pregnancy to the three-month
postpartum period was associated with decreases in mean caloric intakes (2,349
vs. 1,930 calories, p < 0.001 ) as well as decreases in major nutrients of interest,
such as grams of carbohydrate (333 vs. 261 grams, p < 0.001), grams of fat (84
vs. 71 grams, p < 0.012), and grams of protein (85 vs. 71 grams, p < 0.001).
However, out of the 25 questions selected to quantify meat, fish, egg, dairy
product, and fat/oil consumption, only 5 of those questions differed significantly
from the last trimester to the three-month postpartum period including: low fat hot
dog and sausage consumption (0.6 vs. 3 total servings over three-months, p <
0.031): lean lunch meat consumption (14 vs. 22 total servings over three-months,
p < 0.049); ground meat consumption (16 vs. 12 total servings over threemonths, p < 0.016); butter/margarine and other fat consumption on starches and
vegetables (44 vs. 23 total servings over three-months, p < 0.009); and milk
consumption (104 vs. 62 total servings over three-months, p < 0.004).
There were no significant associations between PBDE levels (X, BDE-47,
and BDE-153) and the majority of nutrients consumed during the last trimester or
three-month postpartum period. However, there was a small, but significant
association between BDE-153 and saturated fat consumption during the threemonth postpartum period. For each unit (gram) increase in daily saturated fat
intake, there was a 1.04-fold change (or 4% increase) in BDE-153 levels
(monthly means and participant three-month means) (r = 0.31 p = 0.05,
participant three-month means) (Figure 8). The association between saturated
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fat intake during the postpartum period and BDE-153 persisted after adjusting for
total meat consumption during the postpartum period (r= 0.41 p = 0.03,
participant three-month means) (Table 6). Total meat consumption during the
postpartum period was included as a confounding variable based upon its
association with saturated fat and its effect on the 3 coefficient (Table 7). There
was no association between saturated fat consumption and BDE-153 during the
last trimester.

f
I

6—

r = 0.31 p = 0.05

4—

I1
|i

I3

T
LU

S

0-

§•
E

I

-2-

0

10

20

30

40

SO

60
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Figure 8. The association between BDE-153 levels in breast milk and
consumption of saturated fat during the three-month postpartum period.
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Table 6.

Association between BDE-153 and saturated fat consumption during the threemonth postpartum period

BDE-153 and
saturated fat consumption

Transformed p*

p value

Adjusted p*"

p value'’

1.04

0.05

1.1

0.03

The p coefficients provide the fold change in BDE-153 concentrations in breast miik per
unit of exposure (grams): ^ Adjusted for totai meat intake in the postpartum period.
Note.

Table 7.
The effect of confounding on saturated fat consumption
Saturated Fat Consumption (Exposure)
Confounder

Spearman’s Correlation Coefficient
(p value)

Total meat consumption
during the postpartum period

0.41
(p = 0.009)

Adjusted p
(95% Cl)

1.1*
(1.0,1.1)

Note. * Crude P was 1.04 (95% Cl = 1.0 - 1.1).
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The frequency of meat, fish, dairy product, egg, fat/oil, and vegetable
consumption during the last trimester and three-month postpartum period was
not associated with PBDE levels (X, BDE-47, and BDE-153). However, the
strongest association between ][PBDE levels and diet was seen with total fruit
consumption in the last trimester of pregnancy (Figure 9). For each unit (serving)
increase in fruit, there was a 0.87-fold change (or 13% decrease) in %PBDE
levels (monthly means and participant three-month means) (r = 0.36 p = 0.02,
participant three-month means). The association persisted between fruit
consumption during the last trimester and ][PBDE levels after adjusting for total
calorie and carbohydrate consumption during the last trimester (r= 0.56 p = 0.02,
participant three-month means) (Table 8). Calorie and carbohydrate
consumption during the last trimester were included as confounding variables
based upon their association with fruit intake and their effect on the p coefficient
(Table 9). Similar findings were also seen with BDE-47 and fruit consumption in
the last trimester (monthly means and participant three-month means) (Table 8).
The association was not seen with total fruit consumption in the three-month
postpartum period.
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Figure 9. The association between ^PBDE levels in breast milk and
consumption of fruit during the last trimester.

Table 8.
Association between PBDEs and fruit consumption during the iast trimester
Transformed p®

p value

Adjusted p"

p value'

]£PBDEs and
fruit consumption

0.87

0.02

0.80

0.02

BDE-47 and
fruit consumption

0.86

0.01

0.80

0.02

Note. ®The p coefficients provide the fold change in PBDE concentrations in breast milk per unit
of exposure (servings); Adjusted for calorie and carbohydrate consumption during the last
trimester.
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Table 9.

The effect of confounding on fruit consumption
Fruit Consumption (Exposure)
Confounders

Spearman’s Correlation Coefficient
(p value)

Adjusted p
(95% Cl)

Calorie consumption
during the last trimester

0.48
(p = 0.002)

0 .8 f
(0.71,0.93)

Carbohydrate consumption
during the last trimester

0.56
(p < 0.001)

0.79^
(0.70, 0.92)

Note. ^ Crude p was 0.87 (95% Cl = 0.78 - 0.98).

PBDE Levels in Breast Milk and Maternal Environment
There were no associations between ^PBDE levels in breast milk and
geographical location (e.g. town vs. city), subject occupation, transportation (e.g.
year automobile was purchased, hours per week in the car), and other possible
PBDE exposures (e.g. hobbies that involved using fabric). Usage of household
appliances and electronic equipment was not associated with %^PBDE levels in
breast milk, nor was their year of purchase. The sum of cushioned furniture in
the home was not associated with ^PBDE levels in breast milk, nor was the year
of purchase. Similar findings were also seen with congener (BDE-47 and BDE153) levels and living/occupational characteristics: however, an association was
seen between BDE-153 and the home model (r= 0.51 p = 0.004) (Table 10),
which included the total number of rooms in the home with curtains/valences and
total number of rooms in the home with carpeting. To reach the final home
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model, backward regression was used with a threshold of p < 0.05 for keeping a
variable in the model. The association persisted between the home model and
BDE-153 after adjusting for total rooms in the home and total months at current
residence (r= 0.53 p = 0.02, participant three-month means). Total rooms in the
home and months at current residence were included as confounding variables
based upon their association with the home model and their effect on the p
coefficient (Table 11).

Table 10.
Association between BDE-153 and the home model
Home Model

Transformed p®

p value

Adjusted p"

p value"

Total number of rooms with
curtains/valences

1.24"

0.002

1.21

0.007

Total number of rooms with
carpeting

0.86'=

0.056

0.86

0.08

The p coefficients provide the fold change in BDE-153 concentrations in breast milk per
unit of exposure (rooms); indicates a fold change or 24% increase; ° indicates a fold change or
14% decrease; '‘Adjusted for total rooms in the home and total months at current residence.
Note.
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Table 11.

The effect of confounding on the home model
Confounders

Spearman’s Correlation Coefficient
(p value)

Adjusted p
(95% Cl)

Curtains

Carpet

Curtains®

Carpet"

Total rooms
in home

0.29
(p = 0.13)

0.21
(p = 0.19)

1.22
(1.08, 1.41)

0.84
(0.72, 1.0)

Total months
at residence

0.28
ip = 0.07)

-0.25
(p = 0.11)

1.21
(1.07, 1.40)

0.88
(0.74, 1.0)

Note.

Crude p was 1.24 (95% Cl = 1.1 - 1.4).
" Crude p was 0.86 (95% Cl = 0.74 - 1.0)

discussion
This was the first study to document PBDE levels in breast milk of women
from the state of New Hampshire. Our study had three main findings which
.were: 1.) BDE-153 and its congener pattern; 2.) BDE-153 and its relationship to
age, the home, and saturated fat; and 3.) PBDE levels (X and BDE-47) and its
relationship to fruit consumption.
BDE-153: Congener Patterns
Even though BDE-47 was the predominant congener in most of our
participants’ breast milk samples, a predominance of BDE-153 was observed in
20% of the study population - the highest percentage in the U.S. compared to
7% (Wu et al., 2007), 8% (She et al., 2007), and 10.5% (Sjôdin et al., 2008).
Two European studies that have documented BDE-153 as the predominant
congener in breast milk samples report high seafood consumption in their
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subjects (Fàngstrôm et al., 2005; Ingelido et al., 2007); however, an association
between BDE-153 and seafood was not seen with these studies. It’s noted that
the congener profile for seafood items in these European regions do not reflect
BDE-153 as the predominant congener, which is a similar observation by Ohta
and colleagues (2002) from Japan. The source of BDE-153 is uncertain at this
time given the lack of association with seafood.
The predominant congener pattern (BDE-47 followed by BDE-153) from
our research is similar to the recently reported National Health and Nutrition
Examination Survey (NHANES) data on serum concentrations of PBDEs (Sjôdin
et al., 2008) and breast milk biomonitoring studies from Japan, East coast of the
(

U.S., Pacific Northwest of the U.S. and Canada, Poland, South China, Taiwan,
and United Kingdom (Bi et al., 2006; Chao et al., 2007; Kalantzi et al., 2004;
Kazda et al., 2006; Ohta et al., 2002; She et al., 2007; Wu et al., 2007). Other
breast milk biomonitoring studies have reported predominant congener patterns
of BDE-47 followed by BDE-99 or BDE-100 (Esiami et al., 2006; JohnsonRestrepo et al., 2007; Kazda et al., 2004; Schecter et al., 2003), Earlier work
from Sweden documents BDE-47 as the predominant congener followed by
BDE-99 and BDE-153 (Meironyté et al., 1999). However, in 1972, only two
PBDE congeners were detected in breast milk samples from Sweden (BDE-47
and BDE-153).
Correlation analysis revealed that BDE-153 had no correlation to BDE-47;
however, as the ^PBDE increased in breast milk so did each of the congeners
(Figures 3a and 3b). BDE-153 is considered to be a minor component of the
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pentaBDE and octaBDE commercial products (La Guardia et al., 2006), however,
its estimated half-life is three times longer than that of the BDE-47 congener (6.5
years vs. 1.8 years, respectively) (Geyer et al., 2004), and it’s suggested that
over time, BDE-153 will become the predominant congener in the body
(Sandanger et al., 2007). The apparent increase in the predominance of BDE153 in breast milk samples from New Hampshire is suggestive of a shift in
congener patterns, which couid be related to when our samples were collected
(2005-2006) relative to other studies (e.g. 2004-2005) (Wu et al., 2007).
BDE-153 and Age
Our finding of an association between age and BDE-153 levels is the first
breast milk biomonitoring study to document this positive relationship in 22 to 40
year old women, which may be an indicator of the long half-life of this congener
paired with the physiological demands of lactation on the body. However, we
noted that the association between age and BDE-153 weakened when we
accounted for changes in body composition due to weight changes. Sjôdin and
colleagues (2008) recently reported a linear decrease and positive quadratic
trend with age and serum concentrations of BDE-153 with the highest levels in
the 12 to 19 year old group. These findings are not necessarily comparable to
ours as Sjôdin et al. (2008) looked at age groups from 12 to 19, 20 to 39, 40 to
59, and 60 + years. Sjôdin et al. (2008) did not stratify across their age groups,
such as the 20 to 39 year olds, which was the total range for our study, and the
NHANES population included both males and females.
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PBDE Levels and Exposure Sources
We found a statistically significant association between the home model
and BDE-153. To our knowledge, this is the first study to document a
relationship between BDE-153 levels in breast milk and living environment. It is
unclear from our results whether or not the household items themselves (e.g.
curtains/valences) or the dust they collect are the sources of the exposure, or if
there was an association between household dust concentrations and PBDE
sources (e.g. furniture, curtains, electronics) as recently described by Allen et al.
(2008). We were not able to make this distinction because we did not sample
house dust from the homes of our participants nor did we measure bromine
concentrations in consumer products.
We noted several trends with some of our living environment data. For
example, we found that those who used their microwave less than 6 times per
week had lower ^PBDE levels as compared to those who used it greater than
one time per day (p = 0.086). We also observed lower ^PBDE levels in those
with newer (2000 to present) all-in-one stereo equipment compared to older
models (prior to 1999) (p = 0.086). Those with newer cushioned desk chairs
(2000 to present) had lower XPBDE levels compared to those with older
cushioned desk chairs (prior to 1999) (n = 18, n = 9, respectively, p = 0.053).
We were surprised with the limited findings between PBDE levels and
dietary intake given the recent work by Wu and colleagues (2007) who reported
positive associations between PBDE levels in breast milk and the consumption of
dairy products and meat pre-pregnancy. Our limited findings may be attributed to
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the study’s small sample size and our choice of timing for collecting dietary
information (two 3-month periods). Perhaps if we expanded our time frame for
assessing dietary intake (e.g. throughout the entire pregnancy), we may have
encountered different results, especially since the half-lives of many congeners
are on the magnitude of years. However, we did find a small, but statistically
significant, positive association between BDE-153 levels and saturated fat intake
during the three-month postpartum period. Of interest, this finding was not seen
during the last trimester. The significant finding during the postpartum period
may reflect the metabolic demands that are induced on the body with the process
of lactation. BDE-153 is present in foods that contain saturated fat (e.g. meat,
meat fat, dairy) based on the findings from market basket surveys in the U.S.
(Huwe & Larsen, 2005; Schecter et al., 2004), however, it’s not a predominant
congener in these food samples.
To our knowledge, this is the first study to find a statisticaliy significant,
negative relationship with food consumption and PB.DE levels in breast milk. The
association between fruit consumption and PBDE (X and BDE-47) levels during
the last trimester suggests that fruit may contribute less to PBDE body burden.
Our finding with fruit consumption corresponds with vegan trends that were
observed by Schecter et al. (2006a) where blood levels of PBDEs were lower in
those participants who had longer time periods without consuming foods of
animal origin. However, we were surprised with our lack of findings between
vegetable consumption and PBDE levels.
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Estimated Infant Intake of PBDEs from Breast Milk
In addition to determining levels of PBDEs in breast milk samples from
lactating women, we were able to estimate infant exposure to PBDEs. We
estimated infant intake of PBDEs using previously published guidelines
(Lovelady et al., 2002); however, we did not collect information from our
participants on infant weights and daily breast milk intakes. We estimated the
infant weight based upon the 50*^ percentile weight for age clinicai growth charts
using 4.3 kg for month one, 4.9 kg for month two, and 5.8 kg for month three
(U.S. DHHS, CDC, 2001 ). The majority of participants in our study were
exclusively breastfeeding their infants, so we assumed that the daily
consumption of milk was 800 ml (Dewey et al., 1991 ; Kent et al., 2006).
The estimated median daily intake of PBDEs for an infant from the
Seacoast region of New Hampshire at one month of age was 197 ng/kg body
weight, month two was 140 ng/kg body weight, and month three was 105 ng/kg
body weight. The estimated daily PBDE intake for infants from New Hampshire
is higher compared to breastfed newborns from Taiwan (20.6 ng/kg body weight),
one-month olds from Western Massachusetts (4 ng/kg body weight for three
selected congeners), and three-month olds from Finland and Denmark (16 ng/kg
body weight) (Chao et al., 2007; Johnson-Restrepo et al., 2007; Main et al.,
(
2007). However, the estimated daily intake for PBDEs is higher in Texas (306.6
ng/kg body weight) and Canada (280 ng/kg body weight) compared to New
Hampshire (Jones-Otazo et al., 2005; Schecter et al., 2006b). At this time, it is
not clear as to what the implications are of estimated infant intakes of PBDEs; as
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noted by Jones-Otazo et al. (2005), average intakes are below the chronic oral
reference dose (RfD) that has been established by the U.S. Environmental
Protection Agency (1990a; 1990b; 1995) for penta (RfD = 0.002 mg/kg body
weight/day), octa (RfD = 0.003 mg/kg body weight/day), and deca (RfD = 0.01
mg/kg body weight/day).
Comparing and Contrasting Breast Milk Biomonitoring Studies from the U.S. &
British Columbia
PBDE levels among studies of breast milk in the U.S. and British
Columbia differ in ranges and median values with our study exhibiting the lowest
maximum PBDE level (Table 12) and only one participant who had levels that
were greater than 100 ng/g lipid. However, our median ^PBDE and BDE-47
levels are similar to levels reported by Wu and colleagues (2007) from the
■

Boston, Massachusetts area; it’s noted that our median BDE-47 levels are lower
compared to the NHANES data (Sjôdin et al., 2008). Our study had the lowest
number of congeners represented in ]£PBDEs, our sum did not include BDE-209,
and our percent detection was lower for some of the major congeners (BDE-85,
BDE-154, and BDE-183) compared to Wu et al. (2007) all of which could have
contributed to our lower maximum levels. When comparing the median value of
the predominant congener (BDE-47) in each of the breast milk biomonitoring
studies, the lowest median value was from samples collected in the Western
Massachusetts area (Johnson-Restrepo et al., 2007).
A common finding among studies in the U.S. as well as worldwide (Akutsu et al.,
2003; Bi et al., 2006; Chao et al., 2007; ErdogruI et al., 2004; Esiami et al..
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2006; Ingelido et ai., 2007; Jaraczewska et al., 2006; Kalantzi et al., 2004; Kazda
et al., 2004; Lind et al., 2003; Main et al., 2007; Meironyté et al., 1999; Norén &
Meironyté, 2000; Ohta et al., 2002; Ryan & Patry, 2000), is the predominance of
the BDE-47 congener in breast milk samples. The pentaBDE commercial
mixture contained 24 to 38% of BDE-47. PentaBDE was primarily used to flame
retard polyurethane foams up until its voluntary phase out at the end of 2004
(Hale et al., 2003; WHO, 1994) and BDE-47 was considered a major contributor
to the commercial mixture (Birnbaum & Staskal, 2004). With its persistent and
high lipophilic characteristics as well as its distribution in U.S. homes (Stapleton
et al., 2005; Wu et al., 2007), BDE-47 bioaccumulates in humans (Hale et al.,
2003), which would provide an explanation for its predominance in breast milk
samples.
It can be challenging to compare and contrast the results of breast milk
biomonitoring studies because differences exist among study designs and
congener anaiyses. As noted in Table 12, XPBDEs is defined from 8 to 35
congeners depending on the study. If assessing whether or not labs are
comparable, the percent detection is a useful measure, but not always available
from published studies. In addition, breast milk biomonitoring research in the
U.S. and British Columbia exhibit similarities and differences in their participant
profiies and study designs (Table 13), which couid potentially influence PBDE
levels in breast milk.
Guidelines have been established by the WHO (2007) that recommends
recruiting first-time mothers for biomonitoring studies as previous elimination of
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environmental chemicals through lactation would not have occurred. Most
participants enrolled in our study were first-time mothers (n = 31), but 21.5% (n =
9) had delivered and/or nursed one or more previous children. We did not find a
relationship between parity and PBDE concentrations nor did we see an
association with prior breastfeeding history that would indicate lower PBDE
levels.
Study design recommendations have suggested hand-expressing
samples for breast milk biomonitoring research in order to limit sample
contamination from breast pumps. However, Hooper et al. (2007) and Main et al.
(2007) documented that breast pump use is an acceptable method for milk
collection when analyzing samples for PBDEs, therefore methods of milk
collection (hand vs. pump expression) should not influence PBDE levels. It is
important to ensure that breast milk samples are not exposed to ultraviolet light
or stored in plastic containers; amber glass storage containers can meet both of
these specifications to minimize ultraviolet light exposure and limit adherence of
lipid-soluble PBDEs to the storage container.
Lovelady and colleagues (2002) suggest collecting serial samples rather
than one sample of breast milk to account for changes in environmental
chemicals over time. Our results indicate no significant difference in mean PBDE
levels from months one, two, and three, which is a similar finding to Hooper et al.
(2007) in which the 0-28 days after birth group was not different from the 29 to 56
days after birth group. Additionally, over the long-term. Hooper and colleagues
\
(2007) found that depuration of PBDEs by lactation is slow in primiparae,
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averaging 1 to 3% per month or a 12 to 18% decrease after six months.
Consequentiy, it appears that one breast milk sample would estimate PBDE
levels.
There appears to be a gap in the biomonitoring literature that evaluates if
the time of day and/or quantity of milk collected (e.g. complete expression vs.
foremilk expression) influences lipid-adjusted PBDE levels in breast milk. It’s
noted that collection amounts vary from study to study and most likely collection
times (Table 13); however, median ][PBDE and BDE-47 levels are similar
between Boston, Massachusetts (Wu et al., 2007) and our work (Table 12)
suggesting that a standardized timing protocol for milk collection and a complete
expression may not be necessary. This gap in knowledge could be answered in
future breast milk biomonitoring research of PBDEs.
Strengths and Limitations of Our Research
There were several strengths to our study. First, the collection of serial
breast milk samples enabled us to evaluate changes in PBDE levels over time.
Our results further contribute to a small body of evidence that minimal changes
exist in PBDE levels in breast milk over the first three-months postpartum. An
additional strength to our study was a standardized milk collection protocol and
the collection of a complete expression, which provided information on these
parameters and their influence on lipid-adjusted PBDE ievels in breast milk.
We also viewed our survey work as strengths to our study because this
evaluated potential exposure sources. To our knowledge, this is the first study to
inquire about year of purchase on items in the mother’s environment that are part
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of her day-to-day living, such as electronics, appliances, and cushioned furniture.
We also standardized lifestyle and living environment questions from the Greater
Boston PBDE Body Burden Project (Wu et al., 2007). Although we had a
different population in our study, we had similar findings for questions such as
smoking, occupational, and hobby exposures. We attempted to reduce
measurement error by pilot testing the Maternal Environment Survey prior to its
implementation.
The use of a validated food frequency questionnaire was a strengtfvto our
study: we were confident with the accuracy of the instrument used to assess
dietary intake based upon its validation for the Women’s Health Initiative
(Patterson et al., 1999). In addition, we obtained a comprehensive analysis of
125 nutrients, and quantified the frequency and amount of food consumption for
27 selected questions, which provided a substantial amount of dietary
information - an important aspect given that diet is considered to be a source of
exposure.
In general, collecting dietary information can pose a challenge in obtaining
accurate information due to prevarication bias, the reliance on memory, and the
estimation of portion sizes. As noted by Willet (1990), food frequency
questionnaires have their drawbacks including restrictions in collecting
information with fixed food lists, which we encountered as we were unable to
distinguish between kinds of dairy fat consumed since some participants included
multiple types. Since Wu and colleagues (2007) found an association between
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XPBDE levels In breast milk and consumption of dairy fat, this would have been
an important aspect to evaluate from our data.
Our findings are limited due to the small sample size and our specific
population of nursing mothers, therefore our results may not be applicable to the
general population. As noted from previous research, infants ingest more
PBDEs compared to adults (Jones-Otazo et al., 2005; Schecter et al., 2006), and
males are 2.1 times more likely to be above the 95*^ percentile for BDE-153 as
compared to females (Sjôdin et al., 2008).
Conclusions and Future Directions for Breast Milk Biomonitoring of PBDEs
This was the first study in the state of New Hampshire to document and
evaluate PBDE levels in nursing mothers over time. Our results indicate that
PBDE levels from New Hampshire are within the range that has been reported in
the U.S., and that levels are stable during the first three-months of lactation. Our
findings revealed a higher predominance pattern with BDE-153 compared to
other studies, which may be reflective of its long half-life. Our data indicates that
PBDE levels are influenced by age, diet, and the home environment. Our diet
and home environment findings contribute to the limited body of knowledge on
exposure sources of PBDEs. The negative association between fruit
consumption and PBDE (% and BDE-47) levels during the last trimester was
surprising, and suggests that fruit may contribute less to PBDE levels in the
body.
In the future, it will be important to document time-trends of PBDEs given
the recent phase-out of pentaBDE and octaBDE commericial products and to
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further evaluate geographical trends in the U.S. Lastly, further research should
assess for potential health consequences associated with PBDE body burden
and the nursing infant, with a focus on the long half-life congener BDE-153.
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CHAPTER V

MANUSCRIPT 2: DEVELOPING A BIOMONITORING
COMMUNICATION PAMPHLET FOR POTENTIAL PARTICIPANTS IN A
BREAST MILK BIOMONITORING STUDY

introduction
The National Research Council (2006) emphasizes early planning as an
important component in communicating biomonitoring information. Early
planning enables researchers to assess the needs of the study population and to
establish partnerships with other constituencies in formulating public health
messages. Early planning also encourages researchers to consider both
practical and research-based communication recommendations.
Practical recommendations focus on educational aspects, whereas,
research-based recommendations promote the advancement of biomonitoring
communication (National Research Council, 2006). Practical biomonitoring
communication recommendations highlight the following areas: communication
sponsorship, use of consistent terminology and concepts, expansion of
biomonitoring education to the public on how to interpret biomonitoring results,
communication training for organizations and professionals, and public
documentation of ways to reduce exposures. Research-based recommendations
emphasize the following areas: identification of scientist and non-scientist beliefs
about exposures and health effects, assessment of current biomonitoring
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communication methods and its impact on the public, identification of the public’s
perception regarding uncertainties in biomonitoring, and identification of the
public’s beliefs about risk reduction. Employing aspects of these communication
recommendations would enhance the efforts of biomonitoring research.
If communication is lacking between biomonitoring researchers and the
general public, then the results of biomonitoring studies are subject to
misinterpretation and misuse, which can lead to public health messages that
induce confusion, conflict and anxiety. For example, occasionally, the media will
become aware of biomonitoring research, and will provide a condensed,
simplified version of the results (Bates et al., 2005). Often, these types of
messages present a communication risk, particularly if the biological specimen is
sensationalized with a degree of harm, which can happen when environmental
chemicals are detected in breast milk.
Breast milk is a valuable matrix for monitoring body burdens of
environmental chemicals: however, there are positive and negative aspects when
using breast milk to assess human exposure to environmental chemicals (Fenton
et al., 2005; Hooper & She, 2003). Fenton and colleagues (2005) identify
limitations with using breast milk in biomonitoring studies as the interpretation
and communication of study results have the potential for affecting breastfeeding
rates if inaccurate messages are provided to the public. Even though there are
limitations associated with breast milk biomonitoring studies, positive aspects
have been identified including the collection of a biological specimen with a high
fat content. This positive aspect is an important consideration for iipid-soluble
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environmental chemicals - particularly those that have been steadily rising in
their production, use, and presence in the environment and in humans including
synthetic flame retardants such polybrominated diphenyl ethers (PBDEs).
PBDEs in breast milk were first reported by Krüger (1988) in German
samples, and later by Meironyté et al. (1999) in Swedish samples. PBDE
concentrations in Swedish breast milk samples increased from 1972 to 1997, and
it was determined that levels were doubling every five years while levels of other
environmental chemicals (PCBs and DDT) were decreasing during this same
time period (Meironyté et al., 1999; Norén & Meironyté, 2000). Documenting
this exponential increase in PBDEs has resulted in breast milk biomonitoring
initiatives around the globe, but with limited consideration to practical and
research-based communication recommendations. One of the primary research
objectives of Biomonitoring PBDEs in Lactating Women was to develop an
informative, yet réassuring communication pamphlet to educate potential
subjects about the research without scaring mothers away from nursing their
infants.
the process
To address this objective, we drafted a communication pamphlet. The
format of the pamphlet contained short sections about the research study, body
burden, what PBDEs are and where they come from, why we are measuring
PBDEs, what we hope to learn from the study, and the importance of
breastfeeding. The final draft of the communication pamphlet also included a
section on “frequently asked questions”.
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As part of the communication pamphlet development phase, we
collaborated with a health promotion advisor from the New Hampshire
Department of Health and Human Services (DHHS), a faculty member from the
Family Research Laboratory at UNH, the New Hampshire Breastfeeding Task
Force and a focus group of women from the community. This collaboration
provided us with valuable feedback on the content and language of the pamphlet.
Our first collaborative meeting was in March 2005 with the DHHS health
promotion advisor and the faculty member from the Family Research Laboratory.
Their primary recommendations were to eliminate the technical language in order
to decrease the reading level from 12^*^ grade to 8“^ grade. In addition, they
recommended that the pamphlet be visually appealing and be reassigned a less
scientific name. The project’s secondary name became Steps to a Healthy
Future.
Our second meeting was in April 2005 with 20 members of the New
Hampshire Breastfeeding Task Force. The members of the Task Force are
primarily registered nurses and registered dietitians who are lactation specialists.
This meeting provided valuable input regarding appropriate breastfeeding
language and further elimination of technical wording. An added advantage of
this meeting was that members of the Task Force provided helpful suggestions
on our biomonitoring research design including sample collection time, sample
;
size, breastfeeding support to participants and information on personal use vs.
rental breast pumps.
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Our third meeting was in May 2005 when we conducted a six person, one
hour focus group to assess the content of the pamphlet. We recruited women
from the UNH campus who were currently breastfeeding or had breastfed their
child within the last two years. We provided background information on the
study, reviewed each section of the communication pamphlet, and collected
verbal and written feedback from the focus group participants. The verbal
feedback emphasized refinement of language to further improve the readability of
the communication pamphlet. The written feedback was collected by having
participants compiete an anonymous 10-question survey about the content and
clarity of the pamphlet at the end of the focus group session. The written
feedback directed us to emphasize the heaith effects of PBDEs, participant time
commitment and what will happen with the final results of the study.
The communication pamphlet was completed in August of 2005. The
final format was an eight page pamphlet with readability statistics at the 5‘^ grade
reading level. Approximately 1500 copies of the pamphlet were distributed to
lactation consultants and placed in eight locations around the Seacoast area of
New Hampshire (Dover Pediatrics, Exeter Hospital Family Center, Harbour
Women’s Health, Lamprey Health Care, Portsmouth Regional Hospital,
Rochester Women, Infants & Children Clinic, Seacoast Area La Leche League,
and Wentworth Douglass Hospital) for subject recruitment.
Participants were recruited from the Seacoast region of New Hampshire
from November 2005 to Juiy 2006. Recruitment was accomplished by iactation
consultants from three area hospitals - Exeter Hospital, Portsmouth Regional
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Hospital, and Wentworth Douglass Hospital -, distribution of the communication
pamphlet, and word of mouth. Approval from each hospital was obtained prior to
working with the lactation consultants. Monthly breastfeeding classes were
attended by the researchers at each of the hospitals to provide study information
and the communication pamphlet to pregnant women. The lactation consultants
provided the communication pamphlet to postpartum women prior to their
discharge from the hospital. In addition, the pamphlet was distributed to
outpatient health care clinics.
the outcome and conclusions
All 40 participants in the Biomonitoring PBDEs in Lactating Women
research study received a copy of the communication pamphlet. Thirty-eight
percent of the participants received the pamphlet from a lactation consuitant;
twenty-eight percent of the participants received the pamphlet at breastfeeding
classes: twenty-three percent through a friend/colleague; and thirteen percent
through picking up the pamphlet at area hospitals or outpatient health care
clinics.
The communication pamphlet assisted us in conveying information
pertinent to our study to potential participants. We discovered that our process,
after the publication of Human Biomonitoring for Environmental Chemicals
(National Research Council, 2006), employed some of the principles of practical
and research-based communication recommendations. For example, our
pamphlet discussed the uncertainties that exist between PBDE leveis in humans
and health effects. Additionally, we included in the communication pamphlet our
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approach on how we would disseminate the results of our study. We decided to
use a ciinicai medicine model approach, which emphasizes minimizing potential
harm from reporting uncertain information (Brody et al., 2007). We informed
participants that they would not receive individual results as there is not enough
information to interpret the meaning of PBDE levels in humans.
It is noted that practical and research-based recommendations
emphasized by the National Research Council (2006) primarily focus on
communicating and interpreting the results for the public. However, our
approach to the communication pamphlet focused on providing information to
potential participants prior to their commitment to our biomonitoring study. In
addition, we focused on fostering partnerships with organizations and
professionals (e.g. New Hampshire Breastfeeding Task Force and lactation
consultants) to provide them with an understanding of biomonitoring and our
research prior to recruiting participants into the study.
For future biomonitoring research, we would utilize this process again.
However, we would assess the effectiveness of our communication pamphlet
with participants who enrolled in the study through either a questionnaire or focus
group. We wouid further implement additional practical and research-based
communication recommendations in an effort to further advance the work of
biomonitoring research.
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CHAPTER VI
CONCLUSIONS AND FUTURE DIRECTIONS

This was the first study in the state of New Hampshire to document and
evaluate PBDE levels in nursing mothers over time. Our results indicate that
PBDE ieveis from New Hampshire are within the range that has been reported in
the U.S., and that levels are stable during the first three-months of lactation. Our
findings revealed a higher predominance pattern with BDE-153 compared,to
other studies, which may be reflective of its long half-life. Our data indicates that
PBDE levels are influenced by age, diet, and the home environment. Our diet
and home environment findings contribute to the iimited body of knowledge on
exposure sources of PBDEs.
We found that our communication pamphlet assisted us in conveying
information pertinent to our study to potential participants. For future
biomonitoring research, we would utilize this process again. However, we would
assess the effectiveness of our communication pamphlet with participants who
enroiled in the study through either a questionnaire or focus group.
In the future, it will be important to document time-trends of PBDEs given
the recent phase-out of pentaBDE and octaBDE commericial products and to
further evaluate geographical trends in the U.S. Lastly, further research should
assess for potential health consequences associated with PBDE body burden
and the nursing infant, with a focus on the long half-life congener BDE-153.
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B io m o n ito r in g P B D E s in L a c ta tin g W o m e n
Focus Group Questionnaire for Educational Tooi
1. After hearing the script, do you feel the importance of breast feeding is
sufficiently emphasized?
Yes

No

If no, do you have suggestions for improving this area?

2. If you were a potential participant, do you feel the information on human
research is helpful?
Yes

No

If no, do you have suggestions for improving this area?

3. Do you understand the term “body burden”?
Yes

No

If no, what would help in clarifying the term?
4. Do you understand why we’ve chosen breast milk as our “window” into the
human body?
Yes

No

If no, what would help in clarifying this area?
5. Can you identify where PBDEs come from?
Yes

No
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6. Can you identify the potential health effects of PBDEs?
Yes

No

7. Do you feel there is enough information on the following areas in regard to
each participant’s obligation to the study:
a. Time commitment
Yes

No

b. The number of breast milk samples that will be provided
Yes

No

c. Subject compensation
Yes

No

8. If you were a participant in this study and PBDEs were detected in your
breast milk, would you stop breast feeding?
Yes

No

How would you feel?
What questions would you have?
9. Do you understand what will happen with the results of the study?
Yes

No

10. Do you have suggestions for the visual component of the educational
tool?
Yes

No

If yes, please describe.
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S te p s

to

a

H e a lth y
F u tu r e

Planning to breast feed?
Would you like to participate in
a research study?
R e a d o n ....
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Overview:

Y O U A R E E L I G I B L E IF ;

•

You are pregnant and plan to breast
feed.
OR
• You are a new mother who has been
breast feeding for less than 2 weeks.

YO UR RO LE W OULD BE;

•

To provide us with up to 9 breast milk
samples over 3 months.

•

To meet with us on 4 occasions (at UNH
or at your home).

•

To complete diet and environment
surveys.

O U R G IF T T O Y O U !

•

A P u rely Yours personal breast pump.
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Our G oal....
To learn more about environmental
chemicals that build up in the body
also known as “body burden.”

H ow does **body b u rd en ” happen?
We are exposed to chemicals each day, and
some are stored in our bodies. We may breathe
in environmental chemicals, eat them in food,
or even absorb them through our skin.

What chem icals are w e interested in?
Since the 1970’s, a family of chemicals that has
increased dramatically in our environment is
p o l y b r o m i n a t e d d i p h e n y l e t h e r s , also
known as PBDEs.
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What are PBDEs?
Chemical flame retardants. They keep
things from burning.

W here are PB D Es found?
PBDEs are in products like couches,
stereos, carpets, television sets, and
computers.

Why m easu re PBDEs?
Research using laboratory animals
suggests that high levels of PBDEs in
animals can interfere with thyroid
hormone, learning, memory, and
behavior.
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Can th e se sam e h ea lth effects
h ap p en in people?
We don’t know. A first step is to
measure PBDEs in people.

H ow w ill w e m easu re PBDEs?
We can measure PBDEs in blood or
breast milk. But, breast milk is a better
window into the human body. W h y ?
PBDEs collect in body fat, and breast
milk contains fat.

W hat w e w ill lea m :
•

This study will help us to leam about
PBDEs in the Seacoast region of New
Hampshire.

•

We hope to find out if there are
relationships between PBDEs, diet and
environment.
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To th an k you.
Each participant will receive a
P u rely Yours personal breast pump.

Breast milk is the most nourishing food you can
give your baby.

Whether or not you decide to participate in the
S teps to a H ealthy F uture study, know that
you are making the right choice in
breastfeeding your baby.
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If you would like more
information on the
S te p s to

a H e a lth y F u tu r e

research study, please contact:

Gale Carey or Rebecca Dunn

a
t
t
h
e
U n ive rsity o f N ew H am pshire,
6 0 3 -8 6 2 -2 5 5 0

University

of

New Hampshire

150

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

F req u en tly A sked Q uestions
1. Will my participation interfere with breast
feeding my baby?
No

2. How many breast milk samples will I provide?
A

m axim um o f 9 sam ples

3. What is the size of each sample?
Each sam ple w ill be one complete expression from
one breast.

4. Will I receive instructions on how to collect and
store breast milk samples?
Yes, this w ill happen on you r first visit with us.

5. What if I have difficulty breast feeding?
Breast feeding support is available from a
professional lactation consultant.

6. What if I have to stop breast feeding?
I f you stop breast feeding due to unforeseen
circumstances, ju s t let us know. You are free to
leave the study at any point.
1. What will happen to the results of the study?
The anonymous results w ill be published in a
scientific journal. '

8. Will I receive my PBDE levels?
No, individual levels w ill not be provided as there is
not enough information to know w hat the levels
m e a n . B u t , y o u w i l l re c e iv e a s u m m a r y o f th e

findings and the pu blish ed report.
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U n i v e r s i t y 0/ N

ew

H a m p s h ir e

INSTITUTIONAL REVIEW BOARD FOR THE PROTECTION OF HUMAN SUBJECTS IN RESEARCH

INFORMED CONSENT FOR PARTICIPANTS:
STEPS TO A HEALTHY FUTURE

Purpose:

The purpose of this study is to collect Information on levels of polybrominated diphenyl ethers (PBDEs) In
breast milk, and to determine If there is a relationship between PBDE level, maternal characteristics and
the environment.

Description: You are being asked to participate in a 3-month study through the University of New Hampshire. We are
In need of 100 lactating women, ages 22 to 40, who are In the early stages of breastfeeding (less than 2
weeks) or In the last trimester of pregnancy and plan on breastfeeding. We are asking for a maximum of
9 breast milk samples during the first three months of breast feeding. One sample is the equivalent of
one complete expression from one breast. You will provide up to 3 sampies at the end of the first,
second, and third month of breast feeding.
You are being asked to completely express milk from one breast In the morning on 3 successive days,
once per month for three months. You are being asked to gently mix the milk and transfer your breast
milk sample to a storage container and place It In the refrigerator.
You are being asked to visit with the University of New Hampshire researchers on 4 occasions over a 3month period for a total of approximately 6 hours. On the first visit, you will be oriented to the study's
purpose and design, asked to complete a food frequency questionnaire and a maternal characteristics
survey and sign the subject consent form. You will receive Instruction on breast milk expression via a
personal use breast pump, sample collection procedure and sample storage. You will be given a kit
containing written instructions, milk storage containers, and a milk transport cold box (if needed).
The second visit will occur after 1 month. You will surrender your first month’s samples (up to 3 samples)
and meet with the researchers to answer any questions. You will be asked to complete an environmental
survey. The third visit will occur after the second month.
You will surrender the second month's samples
(up to 3 samples) and meet with the researchers to answer any questions. The fourth visit will occur at
the end of the study, when you will surrender the third month's samples (up to 3 samples), complete a
food frequency questionnaire and receive study debriefing.
To show our appreciation for your time, you will recqlve a personal use breast pump and pumping kit
during your first visit with the researchers. In addition, you will also be provided with breast feeding
support from a professional lactation consultant.
We will share our results with the scientific community; the route by which scientists communicate with
their peers and the larger community. We will provide you with the same published Information. After we
have published our results, you may hear about the study on television or In the newspaper.
To ensure confidentiality of subject Information, all data will be stored In a locked room within the graduate
student office (418 Kendall Hail) at the University of New Hampshire. Data will be coded to Insure your
privacy. You will be assigned a number, which will be used on all the records of data collected and no
names will be disclosed.
Potential
Risks;

Risks to you could be psychological harm. Although we will release only cumulative data on all
subjects, not Individual data on each subject (as there Is no context In which to evaluate this data),
you may feel anxious knowing that your breast milk contains PBDEs. In order to address this
possibility, you will be asked to view our education tool at the outset of the study.
Although unlikely, some slight breast discomfort may occur due to the use of the breast pump.
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1.

You understand that the use of human subjects in this project has been approved by the University of New
Hampshire Institutional Review Board for the Protection of Human Subjects In Research.

2.

You understand the purpose of this research project, the procedures to be foilowed, the expected duration of your
participation, and have viewed the educational tool.

3.

You have received a description of any reasonable foreseeable risks or discomforts associated with being a subject
In this research, have had them explained to you, and understand them.

4.

The Investigator seeks to maintain the confldentlality of all data and records associated with your participation In this
research. You should understand, however, there are rare Instances when the Investigator Is required to share
personally-ldentlflable Information (e.g., according to policy, contract, and regulation). For example. In response to
a complaint about the research, officials at the University of New Hampshire, designees of the sponsor(s), and/or
regulatory and oversight government agencies may access research data. You also should understand that the
investigator is required by law to report certain Information to government and/or law enforcement officials (e.g.,
child abuse, threatened violence against self or others, communicable diseases).

5.

As a participant, you have the right to revoke your consent to use personal health Information. If you chose to do
so, contact the Project Director, Rebecca Dunn at 603-862-2550. There Is the potential risk that personal health
Information provided to others has the potential risk of being re-dlsclosed.

6.

You understand that your consent to participate in this research is entirely voluntary, and that your refusal to
participate will Involve no prejudice, penalty or loss of benefits to which you would otherwise be entitled.

7.

You further understand that if you consent to participate, you may discontinue your participation at any time without
prejudice, penalty, or loss of benefits to which you would otherwise be entitled.

8.

You confirm that no coercion of any kind was used In seeking your participation in this research project.

9.

In the unlikely event that physical Injury should occur from participating in this project, medical treatment should be
sought from your own health care provider. No compensation for Injury is available. If you are a UNH student and
have a paid health fee, you may be seen at the UNH Health Services.

10.

Information on University policy and procedure for research involving human subjects can be obtained from Julie
Simpson at the Human Subjects Review Board, Office of Sponsored Research at 862-2003. Please call Dr. Gale
Carey or Rebecca Dunn at the numbers below if you have questions regarding the procedures or any other aspect
of this study. The Steps to a Healthy Future research study will expire In summer 2008 when data collection, data
analysis and reporting of results Is completed.
Gale B. Carey, Ph.D.
603-862-4628

Rebecca L. Dunn, M.A., R.D., L.D.
603-862-2550

I have read the following Information and have had all questions concerning this study answered to my satisfaction.
The Information obtained will be treated as privileged and confidential and will not be released without my consent.
However, this Information may be used for statistical or scientific purposes with my right of privacy retained. 1
understand and agree that In the event of Injury, which I may sustain as a result of my participation, no financial
compensation Is available but medical treatments within the limits of treatment normally offered by the University of
New Hampshire Health Center will be available. I understand that I will be assessed a fee for any medical services.

Subject Signature

Witness Signature

Date

Steps to a Healthy Future
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APPENDIX E

COLLECTION SCHEDULE
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APPENDIX F
PARTICIPANT LABEL
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Subject #:_

Date Pumped:

_Time Pumped:

Time of Last Feeding:.
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APPENDIX G

PARTICIPANT INVENTORY SPEADSHEET
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APPENDIX H

PBDE LEVELS IN INDIVIDUAL BREAST MILK SAMPLES
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Appendix H: PBDE levels In breast milk samples from month one
Percent Lipid
BDE28/33 BDE47 BDE85
Month 1 Subject #
Month 1 101-05
3.7
2.9
19.2
0.3
Month 1 102-05
4.5
2.6
22.7
0.2
Month 1 103-05
5.0
5.4
59.0
0.9
Month 1 104-05
5.0
29.4
0.2
2.6
Month 1 105-05
2.5
4.4
0.5
0.1
Month 1 106-06
3.8
24.4
1.8
0.4
Month 1 107-06
3.4
0.3
4.9
0.1
Month 1 108-06
2.9
0.6
ND
5.1
Month 1 109-06
3.4
13.7
1.3
0.1
Month 1 110-06
2.8
2.1
33.7
0.5
Month 1 111-06
4.2
1.7
26.1
0.5
Month 1 112-06
2.8
0.4
3.7
ND
Month 1 113-06
2.1
27.1
2.9
ND
Month 1 114-06
2.5
0.6
3.7
ND
Month 1 115-06
, 2.7
3.4
35.5
ND
Month 1 116-06
4.4
1.6
14.3
0.1
Month 1 117-06
2.5
0.6
6.2
ND
Month 1 119-06
4.6
2.6
16.7
ND
Month 1 120-06
4.3
1.6
14.9
0.2
Month 1 121-06
1.7
13.0
ND
4.3
Month 1 122-06
1.6
7.7
ND
0.5
Month 1 123-06
2.1
1.8
25.3
0.3
Month 1 124-06
4.3
0.7
5.9
0.2
Month 1 125-06
11.4
ND
1.7
1.2
Month 1 126-06
3.0
0.9
8.2
ND
Month 1 127-06
3.2
8.1
ND
1.0
Month 1 129-06
2.5
34.9
ND
3.3
Month 1 130-06
ND
2.0
2.2
19.1
Month 1 132-06
4.4
2.2
38.9
0.6
Month 1 133-06
1.6
1.1
11.4
0.2
Month 1 134-06
0.2
2.5
1.4
11.5
Month 1 135-06
4.5
0.8
5.1
0.1
Month 1 136-06
0.4
3.5
2.9
33.7
Month 1 137-06
4.3
1.1
9.6
0.1
Month 1 138-06
31.5
3.1
3.5
0.8
Month 1 139-06
19.4
2.5
4.5
0.3
Month 1 141-06
4.8
0.8
9.6
0.1
Month 1 142-06
1.4
9.9
0.2
4.6
Month 1 143-06
4.2
0.9
8.8
0.1
Month 1 144-06
0.2
2.0
1.0
11.0
Minimum
Maximum
Median
Mean
Note.

1.6
5.0
3.3
3.3

0.3
5.4
1.5
1.8

3.7
59.0
13.4
17.5

< DL
0.9
0.2
0.3

BDE99

BDE100 BDE153 BDE154 BDE183 IP B D E

4.4
2.8
4.6
3.6
0.9
3.7
1.2
0.7
1.4
6.6
4.1
ND
3.8
0.6
5.0
2.6
1.5
2.2
2.9
1.1
ND
3.6
0.8
1.4
ND
ND
3.0
2.5
5.7
1.7
1.4
0.7
3.5
0.8
5.2
2.6
1.5
1.8
■ 1.1
2.2

3.6
ll
15.3
2.8
0.8
2.7
0.8
0.6
0.8
4.5
4.9
0.4
2.7
0.4
12.8
3.6
1.8
2.0
2.7
2.6
1.6
7.6
0.8
2.3
0.8
2.9
9.5
1.6
6.2
2.1
2.4
0.8
3.3
4.5
8.8
4.3
1.8
3.0
1.2
1.8

4.6
20.4
10.4
2.2
1.8
5.2
1.1
2.7
0.8
9.0
4.5
9.9
3.9
1.5
109.6
7.4
97.7
0.7
1.6
27.3
2.4
28.4
1.6
8.7
6.9
9.9
4.7
1.7
3.2
23.6
8.2
1.1
1.3
13.5
5.2
13.7
7.1
7.2
1.5
3.5

0.3
0.1
0.6
0.2
ND
0.2
0.1
ND
0.1
0.3
0.3
ND
ND
ND
0.5
0.1
ND
0.1
0.1
0.1
ND
0.4
0.03
ND
ND
0.1
0.2
ND
0.4
ND
0.1
0.1
0.2
0.1
0.4
0.2
0.1
0.1
0.1
0.1

0.1
0.04
0.1
0.1
0.1
ND
ND
ND
ND
0.21
ND
ND
ND
ND
ND
ND
ND
ND
0.1
0.1
2.3
ND
0.7
ND
0.2
0.1
ND
0.3
ND
ND
ND
ND
ND
ND
ND
ND
ND
ND
ND
ND

35.4
50.9
96.3
41.0
8.6
38.4
8.4
9.7
18,2
56.7
42.1
14.3
40.5
6.8
166.7
29.9
107.7
24.3
24.1
45.9
14.6
67.3
10.7
25.0
17.1
22.1
55.7
27.5
57.2
40.1
25.3
8.7
45.2
29.6
55.5
45.0
21.1
23.6
13.7
19.7

<DL
6.6
2.4
2.6

0.4
15.3
2.5
3.4

0.8
109.6
4.9
11.9

<D L
0.5
0.1
0.2

< DL
2.3
0.1
0.4

6.8
166.7
28.6
37.3

PBDE levels are reported with non-detects (NO) = 0.
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Appendix H; PBDE levels In breast milk samples from month two
Percent LIpId
Month 2 Subject #
Month 2 101-05
Month 2 102-05
Month 2 103-05
Month 2 104-05
Month 2 105-05
Month 2 106-06
Month 2 107-06
Month 2 108-06
Month 2 109-06
Month 2 110-06
Stability 110-06"

2.6
4.6
4.4
4.9
2.5
3.3
2.4
4.4
4.5
3.0

Month 2 111-06
Month 2 112-06
Month 2 113-06
Month 2 114-06
Month 2 115-06
Month 2 116-06
Month 2 117-06
Month 2 119-06
Month 2 120-06
Month 2 121-06
Month 2 122-06
Month 2 123-06
Month 2 124-06
Month 2 125-06
Month 2 126-06
Month 2 127-06
Month 2 129-06
Month 2 130-06
Month 2 132-06
Month 2 133-06
Month 2 134-06
Month 2 135-06
Month 2 136-06
Month 2 137-06
Month 2 138-06
Month 2 139-06
Month 2 141-06
Month 2 142-06
Month 2 143-06
Month 2 144-06

4.0
1.9
2.6
1.3
4.0
2.4
4.4
3.5
1.4
3.2
1.5
2.3
1.9
2.9
4.1
1.1
1.8
2.4
8.5
1.8
5.7
4.3
6.0
3.5
2.4
1.9
3.1
5.7
2.2
2.1

Minimum
Maximum
Median
Mean

1.1
8.5
2.9
3.3

Note.

LIpId* BDE28/33 BDE47 BDE8S BDE99 BDE100 BDE1S3 BDE154 BDE183 yPBDE

3.0

5.2

3.0
2.7 ,
4.7
2.9
0.4
1.6
0.4
0.5
1.3
2.2

15.4
22.9
54.1
32.6
3.9
21.0
7.6
5.0
14.5
35.8

0.2
0.2
0.8
0.3
0.1
0.2
0.1
ND
0.1
ND

2.3
3.1
4.4
4.1
ND
2.8
1.9
0.8
1.4
7.3

2.7
2.1
15.7
3.2
0.7
2.2
0.9
0.7
0.8
4.2

4.0
20.0
11.6
2.1
1.6
4.1
1.0
2.7
1.0
7.9

0.3
0.1
0.7
0.2
ND
0.1
0.1
ND
ND
0.3

ND
0.02
0.1
ND
ND
ND
ND
ND
ND
0.4

27.8
51.0
92.2
45.4
6.6
32.0
11.9
9.8
19.1
58.1

2.4
1.7
0.4
2.1
0.8
2.7
1.6
0.5
2.4
1.8
1.5
0.5
1.9
0.9
1.3
1.1
1.0
3.3
2.0
1.9
0.9
1.3
0.8
2.3
1.1
3.3
4.4
0.7
1.4
0.9
0.9

37.4
26.6
4.3
19.5
4.0
29.6
13.8
5.0
17.4
19.2
11.1
6.2
27.0
9.0
10.4
10.1
7.3
33.7
18.0
33.3
10.4
10.2
5.5
27.2
9.1
29.0
20.2
8.6
9.3
8.6
9.6

ND
ND
ND
ND
ND
ND
0.2
ND
ND
0.3
ND
ND
0.3
0.2
ND
ND
ND
2.1
0.2
0.5
0.3
ND
0.1
0.3
ND
0.7
0.3
0.1
0.2
0.1
0.1

9.8
4.1
ND
2.5
ND
6.6
2.4
1.2
2.3
3.9
ND
ND
4.3
1.8
1.4
1.6
ND
2.7
2.6
4.9
2.0
1.0
0.6
2.5
0.8
4.3
3.2
1.5
1.6
1.2
1.5

5.4
5.0
0.5
2.0
0.4
10.4
3.3
1.3
2.0
3.1
2.3
1.2
7.8
1.1
2.1
1.1
3.7
8.5
1.5
5.5
2.1
2.3
0.8
2.7
4.9
7.9
4.8
1.9
3.1
1.3
1.4

8.7
5.2
11.1
3.1
1.7
83.8
6.9
76.1
0.9
1.5
21.4
2.0
29.1
1.5
7.0
8.3
15.1
3.9
1.1
3.1
24.6
8.3
1.1
1.1
16.8
4.6
16.7
8.2
8.3
1.6
2.9

0.3
0.3
ND
ND
ND
0.6
0.1
0.1
0.1
0.2
0.1
ND
0.4
0.1
0.1
0.1
ND
ND
0.1
0.3
ND
0.1
0.1
0.1
0.1
0.3
0.3
0.1
0.1
ND
ND

0.2
ND
ND
ND
ND
ND
ND
ND
ND
ND
0.3
1.1
ND
0.7
0.2
0.2
ND
ND
ND
ND
ND
ND
0.3
1.3
0.3
ND
ND
ND
ND
ND
ND

64.2
43.0
16.4
29.2
6.9
133.7
28.3
84.1
25.2
30.0
36.7
11.0
70.7
15.2
22.4
22.4
27.0
54.1
25.5
49.5
40.2
23.3
9.2
37.5
33.1
50.2
49.8
21.2
24.0
13.6
16.5

0.4
4.7
1.4
1.7

3.9
54.1
12.4
16.6

<DL
2.1
0.2
0.3

<DL
7.3
2.4
2.7

0.4
15.7
2.1
3.2

1.0
83.8
4.3
10.8

<DL
0.7
0.1
0.2

<DL
1.3
0.3
0.4

6.6
133.7
28.1
35.1

PBDE levels are reported with non-detects (ND) = 0; 'D ata represents the percent llpid content from the stability study,

“ Data In the rectangular box represents the congener profiles of the sample from the stability study.

|

|
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Appendix H: PBDE levels in breast milk samples from month three
Percent Lipid
Month 3 Subject #
Month 3 101-05
Month 3 102-05
Month 3 103-05
Month 3 104-05
Month 3 105-05
Month 3 106-06
Month 3 107-06
Month 3 108-06
Month 3 109-06
Month 3 110-06
stability 110-06"
Month 3 111-06
Month 3 112-06
Month 3.113-06
Month 3 114-06
Stability 114-06"
Month 3 115-06
Month 3 116-06
Month 3 117-06
Month 3 119-06
Month 3 120-06
Month 3 121-06
Month 3 122-06
Month 3 123-06
Month 3 124-06
Month 3 125-06
Month 3 126-06
Month 3 127-06
Month 3 129-06
Month 3 130-06
Month 3 132-06
Month 3 133-06
Month 3 134-06
Month 3 135-06
Month 3 136-06
Month 3 137-06
Month 3 138-06
Month 3 139-06
Month 3 141-06
Month 3 142-06
Month 3 143-06
Month 3 144-06
Minimum
Maximum
Median
Mean
Note.

Llpid*

1.9
2.0
4.6
4.5
1.1
1.7
4.4
1.7
5.7
4.0

3.5

3.8
1.6
1.7
2.0

2.0

4.3
1.2
3.6
3.8
2.7
3.8
3.9
3.3
2.0
3.1
0.9
1.6
2.8
1.3
3.2
1.8
6.8
1.9
5.0
3.5
2.4
3.4
3.6
3.8
2.8
1.4
0.9
6.8
2.9
3.0

3.3
3.1

2.8

3.6
3.7

BDE28/33 BDE47

BDE85

BDE99 BDE100 BDE1S3 BDE1S4 BDE183 IPB DE
34.1
46.4
73.2
42.9
6.8
34.7
11.3
11.2
17.4
67.4
83.3
51.3
17.8
17.5
7.2

2.9
2.6
3.9
2.6 .
0.4
1.5
0.4
0.5
1.2
2.3
3.0
1.9
0.3
1.2
0.7
0.8
2.2
1.8
0.5
2.1
1.8
1.1
0.5
1.6
0.7
1.2
1.4
0.7
3.3
3.1
2.0
1.0
1.2
0.6
2.1
1.0
2.9
4.3
0.7
1.5
0.8
0.9

17.8
20.9
43.5
30.3
3.8
22.5
7.1
5.6
13.2
42.9
49.5
31.3
5.5
11.9
3.8
4.5
22.7
16.0
5.1
15.1
18.3
9.8
5.7
22.5
7.2
9.6
11.9
5.3
33.2
28.8
34.5
9.9
9.4
4.0
25.0
8.9
25.8
19.0
8.2
14.3
8.4
9.7

0.3
0.1
0.7
0.2
0.1
ND
0.1
ND
ND
ND
0.7
ND
0.2
ND
ND
0.1
ND
0.2
ND
ND
0.2
ND
0.4
0.2
ND
ND
ND
ND
1.4
ND
0.6
0.2
ND
0.1
0.3
ND
0.6
0.3
0.1
0.3
0.1
0.2

4.5
2.4
3.6
4.5
ND
3.6
1.5
1.3
1.3
10.2
13.7
5.8
2.5
1.6
0.8
0.8
3.3
3.1
1.0
2.2
3.7
ND
1.0
3.2
1.2
1.3
ND
ND
2.5
3.8
5.8
1.7
1.1
ND
2.5
1.0
4.0
2.8
1.7
4.3
1.4
1.9

3.4
1.8 f
12.0 '
3.0
0.7
2.4
0.8
0.8
0.8
4.7
6.3
5.9
0.8
1.1
0.4
0.6
8.6
3.8
1.3
1.9
3.1
2.3
1.2
6.5
0.8
2.0
0.6
2.6
8.1
2.2
5.9
2.0
2.1
0.7
2.4
4.8
7.1
4.3
1.9
3.6
1.3
1.5

4.9
18.5
8.7
2.2
1.7
4.4
1.2
2.9
0.8
6.9
9.4
5.9
8.5
1.6
1.6
1.7
81.3
8.3
73.7
0.9
1.8
22.1
2.1
24.2
1.6
6.8
11.1
11.3
4.1
2.0
3.3
25.5
7.5
1.0
0.9
18.8
4.1
14.8
7.9
8.2
1.5
3.2

0.4
0.1
0.5
0.2
ND
0.2
0.1
ND
0.1
0.3
0.4
0.4
ND
ND
ND
ND
0.3
ND
0.1
0.1
0.2
ND
ND
0.4 ^
0.1
0.1
ND
ND
0.2
ND
0.4
ND
0.1
ND
0.1
0.1
0.3
0.2
0.1
0.2
ND
ND

0.05
ND
0.10
ND
ND
ND
ND
ND
ND
0.2
0.3
0.10
ND
ND
ND
ND
ND
ND
ND
ND
ND
0.66
0.9
ND
0.7
0.1
0.8
ND
ND
0.9
ND
ND
0.1
ND
0.1
ND
ND
ND
ND
ND
ND
ND

8.5
118.4
33.2
81.6
22.3
29.1
36.0
11.8
58.6
12.5
21.1
25.7
19.8
52.8
40.8
52.5
40.2
21.4
6.5
33.4
34.6
44.9
45.8
20.8
32.3
13.5
17.4

0.3
4.3
1.3
1.6

3.8
43.5
12.6
16.2

<DL
1.4
0.2
0.3

<DL
10.2
2.5
2.8

0.4
12.0
2.1
3.0

0.8
81.3
4.7
10.4

<DL
0.5
0.2
0.2

<DL
0.90
0.14
0.39

6.5
118.4
32.8
34.1

PBDE levels are reported with non-detects fND) = 0; * Data represents the percent llpid content from the statrilltv study

' Data In the rectangular boxes represents the congener profiles of those samples from the stability study.
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APPENDIX I
MATERNAL CHARACTERISTICS SURVEY
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U n i v e r s i t y of N e w H a m p s h ir e

STEPS TO A HEALTHY FUTURE
S urvey#!: Maternal Characteristics
Subject #
Today’s Date

NAME:

A N TH R O PO M ETR IC M EASUREM ENTS:
W EIG H T
(pounds)
(m easured)

H EIG H T
(ft., inches)
(reported)

BM I
W t (kg)/ H t
(calculated)

PR E 
PREGNANCY
W EIG H T
(reported)

Start o f study
(date:
)

End o f study
(date:
)

Would you like a free telephone consultation with a lactation specialist to answer any questions
you m i ^ t have on breast feeding and breast pump use?

Yes

No
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1. Is this your first child?

1.

Yes

No

If no, how many other children have you
delivered? '
2.

Is this your first time breast feeding?

2.

Yes

No

If no, how many other children have you breast
fed?

1

Other

How long did you breast feed your 1®*child
, 2"^ child
,3™ child
,4"'
child
, 5* child .
Please indicate days, months, or years.
3.

Is your infant receiving only breast milk?

3.

Yes

No

If no, what supplementary feeding(s) are you
using?
Formula

Water

Juice

Solid Foods

Other__________ __ _________ ___
How much per day o f each are you
supplementing with:

4. Please indicate your ethnicity.

4.

White, non-Hispanic
Hispanic or Latino

O
O

Black or Afiican American O
American Indian

O

Alaskan Native

^

Asian, Native Hawaiian, or
Pacific Islander

[—|

Other
□
Please specify:________________
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5. Please indicate your level o f education.

5.

Less than high school graduate
High school diploma or GED

6. Please indicate your total household
income.

7. Do you engage in physical activity?

6.

7.

□
□

Some college or technical school

□

College graduate, 2-year degree

□

College graduate, 4-year degree

□

Masters degree

O

Doctoral degree

O

Less than $20,000

□

$20,000 to $34,999

□

$35,000 to $49,000

□

$50,000 and higher

□

Yes

No

If yes, what category best describes you:
I I Any leisure time physical activity
□

Regular and sustained physical activity
for 30 minutes or more 5 times per week

I—I Regular and vigorous activity that
involves large muscle groups for 20
minutes or more three times per week
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H E A L T H H IS T O R Y :

Have you been diagnosed by a health care provider with any o f the following:
Diabetes

Yes

No

Asthma

Yes

No

High Blood Pressure

Yes

No

Heart Disease

Yes

No

High Cholesterol

Yes

No

Digestive Disorders

Yes

No

If yes: Type 1

Type 2

Gestational

If yes, current blood pressure:____________

Is yes, please indicate which disorder(s) by
circling the following:
Crohn’s Disease
Lactose Intolerant
Reflux (Heartburn)

Ulcerative Colitis
Irritable Bowel

Do you have other health issues?
Yes

No

If yes, please explain:

Are you currently taking any medications or dietary supplements?

Are you a vegetarian?

Yes

No

If yes, please list:___

Yes

No

If yes, do you exclude (circle all that apply):
Red meat

Dairy Products

Fish

Poultry

Have you gone on a diet to lose weight in the past three years?

Yes

Eggs

No

If yes, how much weight did you lose?______________________
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Before you became pregnant, did you smoke cigarettes?

Yes

No

a. If yes, how many cigarettes on average did you smoke each day?
b. For how many years had you been sm oking?________

Do you currently smoke?
a.

Yes

No

If yes, how many cigarettes per day? ___________

Do you currently live with or share an office with a smoker?
a.

Yes

No

If yes, how many hours per day are you at home or in the office with a smoker?

Is there anything you want to explain regarding your answers?
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APPENDIX J

FOOD FREQUENCY QUESTIONNAIRE
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A sample of the Food Frequency Questionnaire can be viewed at:
http://www.fhcrc.org/science/shared_resources/nutrition/
Contact information:
Fred Hutchinson Cancer Research Center
1100 FairviewAve. N. M1-B831
Seattle, WA 98109
Email: ffq@fhcrc.org
Tel.: 1-800-460-7270
Fax: 206-667-7864
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APPENDIX K

MATERNAL ENVIRONMENT SURVEY
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U n i v e r s i t y of N e w H a m p s h i r e

STEPS TO A HEALTHY FUTURE
Survey #3: M aternal Environment
Subject #
Today’s Date

R E S ID E N T IA L IN F O R M A T IO N
S E C T IO N A

1. What town do you reside in?

2.

a.

How long have you been at your current residence?

b.

Prior to this residence, where did you live and for how long?

In the past three years, have you lived within a 10 minute walk o f an industrial complex?
(By industrial complex, we mean an area with several manufacturing facilities)
Yes

No

If yes, what types o f industries were located in that complex?

3.

In the past three years, have you ever lived within a 10 minute walk o f any o f the following:
Yes

No

If yes, please check all that apply,
a.

incinerator

c. landfill

b.

garbage processing facility/recycling center

d. sewage treatment plant
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4. Have you ever been in a house, office, or car fire?
Yes

No

5. On average, how many hours per day are you at home, including sleeping hours? (Please
circle one)
a. Less than 9 hours per day
b. 10 to 12 hours per day
c. 13 to 15 hours per day
d. greater than 15 hours per day
6. Are you a stay at home mom?

Yes

No

i. If yes, how long have you been a stay at home mom?
( I f g re a te r th a n 1 y e a r sk ip S E C T I O N B )
O C C U P A T IO N A L IN F O R M A T IO N - S E C T IO N B

1. Are you currently working?
Yes
No
2. Are you on maternity leave from a full-time or part-time job?

Yes

No

I f yo u an sw ered yes to q u e stio n 1 o r 2 , please co m p lete questions a. th ro u g h k .

a. Where do you work? ________________________________________
b. What is your occupation?____________________________________
c. How long have you been at this job?
d. What town do you work in? ______
e. How many days per week do you work?
f.

How long do you work each day? _____

g.

What kind o f work do you do there?_

h. Does this job sometimes involve the manufacturing or processing o f fabrics, plastic,
or foam?
Yes
No
i.

Does this job sometimes involve working on a computer or copy machine?
Yes
No

j.

Is there computer equipment, a fax machine, or a copy machine in your office?
Yes
No

k. Do you sit on a foam or padded chair?

Yes

No
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T R A N S P O R T A T IO N IN F O R M A T IO N
S E C T IO N C

1. Do you drive your own car?

Yes

No

I f yes, an sw e r l a to c. I f n o , skip to I d .

a.

What is the year o f the car you most often drive?

b. Does your car have ripped seats or exposed foam?

Yes

No

c. How many hours per week do you spend in the ca r?_______________
d. Do you regularly (more than once per week on average) drive or ride in a car other
than your own?
Yes
No
I f yes, a n s w e r l e to g. I f n o , sk ip to question 2.

e. What is the year of this ca r? ______________
f.

Does this car have ripped seats or exposed foam?

Yes

No

g. How many hours per week do you spend in that car? _______________
2.

Do you regularly (once or more per week on average) take the bus or commuter rail?
Yes

No

H O U S E H O L D IN F O R M A T IO N
S E C T IO N D

1. How many rooms are in your home (including bathrooms): ___________________
2. Do you have the following products in your home:
a .C u r ta in s /V alences

Yes

No

i. If yes, how many rooms have curtains? __________________________

b .W a ll to w a ll c a rp e tin g

Yes

No

(Note: We don’t mean small area rugs, but carpeting that covers most of thefloor
and is installed with padding underneath)

i. If yes, how many rooms have wall to wall carpeting? _________________
c.

Yes
No
If yes, how many rooms have hardwood flooring?

H a r d w o o d flo o rin g

i.
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d. Coffee maker

Yes

No

i. If yes, how often is the coffee maker used?
1. less than I day per week
2. 1 to 3 days per week
3. 3 to 5 days per week
4. 5 to 7 days per week
5. greater than once per day
ii. When was your coffee maker purchased?
1. 2000 to present
2. 1995 to 1999
3. 1990 to 1994
4. 1985 to 1989
5. Prior to 1984
e.

Yes

M ic r o w a v e

No

i. If yes, how often is the microwave used?
1. less than 4 times per week
2. 5 to 6 times per week
3. 1 to 2 times per day
4. greater than 3 times per day
ii. When was your microwave purchased?
1. 2000 to present
2. 1995 to 1999
3. 1990 to 1994
4. 1985 to 1989
5. Prior to 1984
f.

T o a s te r O v e n

i. If yes,
1.
2.
3.
4.

Yes

No

how often is the toaster oven used?
less than 4 times per week
5 to 6 times per week
1 to 2 times per day
greater than 3 times per day

ii. When was your toaster oven purchased?
1. 2000 to present
2. 1995 to 1999
3. 1990 to 1994
4. 1985 to 1989
5. Prior to 1984
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g. Hair dryer

Yes
i. If yes,
1.
2.
3.
4.
5.

No

how often is the hair dryer used?
less than 1 day per week
I to 3 days per week
3 to 5 days per week
5 to 7 days per week
greater than once per day

ii. When was your hair dryer purchased?
1. 2000 to present
2. 1995 to 1999
3. 1990 to 1994
4. 1985 to 1989
5. Prior to 1984

h.

Television set
i.

ii.

TV Set #1

Yes

No

If yes, how many television sets do you have?

When did you purchase each o f your television sets? Place a check
mark in the appropriate box for each television set.
TV Set #2

TV Set #3

TV Set #4

TV Set #5

TV Set #6

2000 to
present
1995 to 1999
1990 to 1994
1985 to 1989
Prior to 1984
iii.

i.

C om puter

How often is any television on each day?
1. less than I hour per day
2. 1 to 2 hours per day
3. 2 to 3 hours per day
4. 3 to 4 hours per day
5. greater than 4 hours per day
Yes

No

i. If yes, how many computers do you have?
[One computer is the equivalent o f I laptop or 1 desktop (monitor & tower)]
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ii.

When did you purchase each o f your computers? Place a check mark
in the appropriate box for each computer.
C o m p u ter #2

C o m p u ter
#1

C o m p u ter #3

C om puter #4

C om puter #5

C o m p u ter
#6

2000 to
present
1995 to
1999
1990 to
1994
1985 to
1989
Prior to
1984
iii.

j.

How often is any computer left on each day?
1. less than 1 hour per day
2. 1 to 3 hours per day
3. 3 to 5 hours per day
4. greater than 5 hours per day

C o m p u te r P r in t e r

i.

ii.

P rin te r #1

Yes

No

If yes, how many printers do you have?

When did you purchase each o f your printers? Place a check mark in
the appropriate box for each printer.
P rin te r #2

P rin te r #3

P rin te r #4

P rin te r #5

P rin te r #6

2000 to
present
1995 to
1999
1990 to
1994
1985 to
1989
Prior to
1984
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iii.

k.

How often is any printer left on each day?
1. less than 1 hour per day
2. 1 to 3 hours per day
3. 3 to 5 hours per day
4. greater than 5 hours per day

Stereo

Yes
i.

No

If yes, which o f the following do you have for a stereo

(in d ic a te h ow

m a n y o f each);

1.
2.
3.
4.
5.
6.

All-in-one stereo (i.e. “boom box”)________ _______
Receiver
_______
CD player
_______
Cassette player
_______
Speakers_______________________________ _______
Other (__________ )
_______

ii. When did you purchase your stereo equipment? Place a check mark
in the appropriate box for each piece of stereo equipment.
All in One

Receiver

CD Player

Cassette

Speakers

Other

2000 to
present
1995 to 1999
1990 to 1994
1985 to 1989
Prior to 1984
iii.

1.

How often is any stereo left on each day?
1. less than 1 hour per day
2. 1 to 3 hours per day
3. 3 to 5 hours per day
4. greater than 5 hours per day

Bed M attress (th^t you sleep on)
i.

Yes

No

If yes, when was your bed mattress purchased?
1. 2000 to present
2. 1995 to 1999
3. 1990 to 1994
4. 1985 to 1989
5. Prior to 1984

182

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

m.

n.

What is inside the bed pillows you currently use? Is it;
1. foam
2. down
3. both foam and down
4. not certain
5. other (please specify:_________

In the past three years, have you had any furniture in your house such as a sofa or
chair that had crumbling foam?
Yes

0.

J

No

Do you have couches with cushions/padding?

Yes

No

i.

If yes, how many couches do you have with cushions/padding?

ii.

When did you purchase each o f your cushioned/padded couches?
Place a check mark in the appropriate box for each couch.

Couch #1

Couch #2

Couch #3

Couch #4

Couch #5

Couch #6

2000 to
present
1995 to 1999
1990 to 1994
1985 to 1989
Prior to 1984

p.

Do you have

liv in g ro o m /fa m ily ro o m ch airs

Yes

with cushions/padding?

No

i. If yes, how many living room/family room chairs do you have with
cushions/padding?______________________
ii. When did you purchase each o f your cushioned/padded living
room/family room chairs? Place a check mark in the appropriate box

for each chair.
(see next page)
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C h a ir #1

C h a ir #2

C h a ir #3

C h a ir #4

C h a ir #5

C h a ir #6

2000 to
present
1995 to 1999
1990 to 1994
1985 to 1989
Prior to 1984

q. Do you have rocking chairs with cushions/padding?
i.

Yes

No

If yes, how many rocking chairs do you have with cushions/padding?

ii. When did you purchase each o f your cushioned/padded rocking
chairs? Place a check mark in the appropriate box for each rocking
chair.

C h a ir #1

C h a ir

#2

C h a ir #3

C h a ir

#4

C h a ir #5

C h a ir #6

2000 to
present
1995 to 1999
1990 to 1994
1985 to 1989
Prior to 1984

r. Do you have kitchen chairs with cushions/padding?
i.

Yes

No

If yes, how many kitchen chairs do you have with cushions/padding?

ii. When did you purchase each o f your cushioned/padded kitchen
chairs? Place a check mark in the appropriate box for each kitchen
chair.
(see next page)
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C h a ir #1

C h a ir #2

C h a ir #3

C h a ir #4

C h a ir #5

C h a ir #6

2000 to
present
1995 to 1999
1990 to 1994
1985 to 1989
Prior to 1984

s.

Do you have

d in in g ro o m c h a irs

with cushions/padding? Yes

No

i. If yes, how many dining room chairs do you have with
cushions/padding?______________________
ii. When did you purchase each of your cushioned/padded dining chairs?
Place a check mark in the appropriate box for each dining room chair.

C h a ir #1

C h a ir #2

C h a ir #3

C h a ir #4

C h a ir #5

C h a ir #6

2000 to
present
1995 to 1999
1990 to 1994
1985 to 1989
Prior to 1984

t.

Do you have
i.

ii.

d esk c h a irs

with cushions/padding?

Yes

No

If yes, how many desk chairs do you have with cushions/padding?

When did you purchase each o f your cushioned/padded desk chairs?
Place a check mark in the appropriate box for each desk chair.
(see next page)
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C h a ir #2

C h a ir #1

C h a ir #3

C h a ir #4

C h a ir #5

C h a ir #6

2000 to
present
1995 to 1999
1990 to 1994
1985 to 1989
Prior to 1984

u.

Do you have

O th e r #1

o th e r fu r n it u r e

with cushions/padding?

Yes

No

i.

If yes, please indicate what these furniture pieces are?

ii.

When did you purchase each o f these pieces? Place a check mark in
the appropriate box for each piece.

O th e r #2

O th e r #3

O th e r #4

O th e r #5

O th e r #6

2000 to
present
1995 to 1999
1990 to 1994
1985 to 1989
Prior to 1984
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H O B B IE S / C R A F T / H O M E I M P R O V E M E N T I N F O R M A T I O N
S E C T IO N E
T h is section o f questions is a b o u t h ob b ies, c ra fts , o r w o r k a r o u n d th e house th a t yo u m ig h t do
w h e n y o u ’ re n o t a t w o r k .

1.

Do you have any hobbies like arts and crafts or model building or do you do any home
improvement work that involve working with plastic, foam, or fabric?
Yes

No

I f yes:

a.

I n w h a t w a y do yo u w o r k w ith plastic? C h e c k a ll th a t a p p ly .

Cutting/Shredding
Sanding
Burning
Melting
Molding
Other (Please specify:________________________ )
b.

In w h a t w a y do yo u w o r k w ith fo am ? C h e c k a ll th a t a p p ly .

Cutting/Shredding
Burning
Molding
Other (Please specify:________________________ )
I n w h a t w a y do y o u w o r k w ith fa b ric ? C h e c k a ll th a t a p p ly .

Sewing clothing
Furniture repair/reupholstering
Sewing other household items such as curtains or linens
Other (Please specify:________________________ )
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Is th e re a n y th in g yo u w a n t to e x p la in re g a rd in g y o u r answ ers?
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APPENDIX K

FEEDBACK QUESTIONNAIRE
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STEPS TO A HEALTHY FUTURE
We would love your feedback!

Feedback Questionnaire for Maternal Environment Survey

1. How long did the Maternal Environment Survey take to complete?

2. Did you have a hard time answering some of the questions?
If yes, please indicate section and question number and WHY.

3. Were any questions confusing?
If yes, please indicate section and question number and WHY.

4. Did you find it helpful to complete the survey in your home?

5.

D o y o u h a v e a n y s u g g e s t io n s f o r Im p r o v in g t h e s u r v e y ?
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APPENDIX M

INSTITUTIONAL REVIEW BOARD APPROVAL LETTERS
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A

U N IV E R S IT Y 0/ N E W H A M P S H IR E

A p r il 1 8 , 2 0 0 5
D unn, R ebecca
A n i m a l & N u t r i t i o n a l S c ie n c e s , K e n d a ll H a ll
2 1 9 B r ic k y a r d R o a d
N e ls o n , N H 0 3 4 5 7

IRB # :
Study:

3433
B i o m o n i t o r i n g P o l y b r o m i n a t e d D ip h e n y l E t h e r s ( P B D E s ) in L a c t a t i n g
W om en
0 4 /1 8 /2 0 0 5

Approval Date:

T h e I n s t i t u t i o n a l R e v i e w B o a r d f o r t h e P r o t e c t i o n o f H u m a n S u b j e c t s in R e s e a r c h ( I R B )
h a s r e v i e w e d a n d a p p r o v e d t h e p r o t o c o l f o r y o u r s t u d y a s E x p e d i t e d a s d e s c r i b e d in
T i t l e 4 5 , C o d e o f F e d e r a l R e g u l a t i o n s ( C F R ) , P a r t 4 6 , S u b s e c t io n 1 1 0 .

Approval is granted to conduct your study as described in your protocol for
one year from the approval date above. A t t h e e n d o f t h e a p p r o v a l p e r i o d , y o u w ill
b e a s k e d t o s u b m i t a r e p o r t w i t h r e g a r d t o t h e i n v o l v e m e n t o f h u m a n s u b j e c t s in t h i s
s t u d y . I f y o u r s t u d y is s t ill a c t i v e , y o u m a y r e q u e s t a n e x t e n s i o n o f I R B a p p r o v a l .
R e s e a r c h e r s w h o c o n d u c t s t u d i e s in v o lv in g h u m a n s u b j e c t s h a v e r e s p o n s ib i lit i e s a s
o u t l i n e d in t h e a t t a c h e d d o c u m e n t . Responsibilities o f Directors o f Research Studies
Involving
Human
Subjects.
(T h is
docum ent
is
a ls o
a v a ila b le
at
h t t p : / / w w w . u n h . e d U / o s r / c o m p l i a n c e / I R B . h t m l . j P le a s e r e a d t h i s d o c u m e n t c a r e f u l l y
b e f o r e c o m m e n c i n g y o u r w o r k in v o lv in g h u m a n s u b j e c t s .
I f y o u h a v e q u e s t io n s o r c o n c e r n s a b o u t y o u r s t u d y o r t h i s a p p r o v a l , p l e a s e f e e l f r e e t o
c o n t a c t m e a t 6 0 3 - 8 6 2 - 2 0 0 3 o r J u l i e . s i m p s o n @ u n h . e d u . P le a s e r e f e r t o t h e I R B #
a b o v e in a ll c o r r e s p o n d e n c e r e l a t e d t o t h i s s t u d y . T h e I R B w i s h e s y o u s u c c e s s w i t h y o u r
re s e a rc h .

F o r t h e IR B ,

_

^

j Julie F. Sirnpyson

]

ij^anager \ y
cc:

F ile
G a le C a r e y

Research Conduct and Compliance Services, Office of Sponsored Research, Service
Building, 51 College Road, Durham, NH 03824-3585 * Fax: 603-862-3564
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A

U N IV E R S IT Y 0/ N E W H A M P SH IR E

S e p te m b e r 1 6 , 2 0 0 5

R ebecca D unn
A n im a l & N u t r it io n a l S c ie n c e s , K e n d a ll H a ll
2 1 9 B r ic k y a r d R o a d
N e ls o n , N H 0 3 4 5 7
IRB # :
3433
Study:
B io m o n it o r in g P o ly b r o m in a t e d D ip h e n y l E t h e r s ( P B D E s ) in L a c t a t in g W o m e n
Approval Expiration Date:
0 4 /1 8 /2 0 0 6
Modification Approval Date: 0 9 / 1 3 / 2 0 0 5
Modification:
C h a n g e s t o s t u d y a s p e r l e t t e r t o IR B d a t e d A u g u s t 2 6 , 2 0 0 5

T h e In s t i t u t io n a l R e v ie w B o a r d f o r t h e P r o t e c t io n o f H u m a n S u b je c t s in R e s e a r c h ( I R B ) h a s r e v i e w e d
a n d a p p r o v e d y o u r m o d if ic a t io n t o t h is s t u d y , a s in d ic a t e d a b o v e . F u r t h e r c h a n g e s in y o u r s t u d y m u s t
b e s u b m it t e d t o t h e IR B f o r r e v i e w a n d a p p r o v a l p r io r t o im p l e m e n t a t io n .
Approval for this protocol expires on the date indicated above. A t t h e e n d o f t h e a p p r o v a l

p e r io d y o u w ill b e a s k e d t o s u b m it a r e p o r t w i t h r e g a r d t o t h e in v o lv e m e n t o f h u m a n s u b je c t s in th is
s t u d y . I f y o u r s t u d y is s till a c t i v e , y o u m a y r e q u e s t a n e x t e n s io n o f IR B a p p r o v a l.
R e s e a r c h e r s w h o c o n d u c t s t u d ie s in v o lv in g h u m a n s u b je c t s h a v e r e s p o n s ib ilit ie s a s o u t lin e d in t h e
d o c u m e n t . Responsibilities o f Directors o f Research Studies Involving Human Subjects. T h is d o c u m e n t
is a v a ila b le a t h t t o : / / w w w . u n h . e d u / o s r / c o m D l i a n c e / i r b . h t m l o r f r o m m e .
I f y o u h a v e q u e s t io n s o r c o n c e r n s a b o u t y o u r s t u d y o r t h is a p p r o v a l, p le a s e f e e l f r e e t o c o n t a c t m e a t
6 0 3 - 8 6 2 - 2 0 0 3 o r J u li e . s im p s o n @ u n h .e d u . P le a s e r e f e r t o t h e IR B # a b o v e in a ll c o r r e s p o n d e n c e r e l a t e d
t o th is s t u d y . T h e IR B w is h e s y o u s u c c e s s w i t h y o u r r e s e a r c h .
F o r t h e IR B ,

A liU L m iU fU iyV
( l u l i e F . | | m j 2is o n
‘• M a n a g e r '
cc:

F ile
G a le C a r e y

Research Conduct and Compliance Services, Office of Sponsored Research, Service Building,
51 College Road, Durham, NH 03824-3585 * Fax: 603-862-3564
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